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ABSTRACT  
Background: Sepsis, a leading cause of US deaths, is associated with high mortality, 
although advances in early recognition and treatment have increased survivorship. Many 
aspects of sepsis pathophysiology and epidemiology have not been fully elucidated; the 
heterogeneous nature of infections that lead to sepsis has made fully characterizing the 
underlying epidemiology challenging.  
Methods: The University HealthSystem Consortium (UHC) from 2011-2014 and the 
Cerner HealthFacts
®
 database from 2008-2014 were used. We examined associations 
between infection source and in-hospital mortality in the UHC dataset, stratified by age 
and presenting sepsis stage. We examined recent temporal trends in present-on-admission 
(POA) sepsis diagnoses and mortality and predictors of 30-day sepsis readmissions 
following sepsis hospitalizations using the HealthFacts
®
 dataset. 
Results: Patients with sepsis due to genitourinary or skin, soft tissue, or bone sources had 
lower mortality than patients with sepsis due to respiratory sources regardless of age or 
presenting sepsis stage. Overall diagnoses of sepsis increased from 2008-2014; however, 
POA diagnoses and case fatality rates decreased. Factors that predicted re-hospitalization 
for sepsis included discharge to hospice, admission from or discharge to a skilled nursing 
facility, and abdominal infection.  
Conclusion: Further investigation will reveal more detail to explain the impact of 
infection source on in-hospital sepsis mortality for all age groups and sepsis stages. 
Decreasing mortality rates for all POA sepsis stages and all age groups suggest current 
approaches to sepsis management are having broad impact. Sepsis survivors are at 
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significant risk for re-hospitalization; further studies are needed to understand the post 
discharge risks and needs of survivors. 
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CHAPTER I 
 INTRODUCTION 
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Sepsis 
 Sepsis is a pathophysiologic over-response and resulting immune dysregulation to 
an infection. The 2014 guidelines typically subdivide sepsis into three stages of 
increasing clinical severity: sepsis, severe sepsis, and septic shock. Over a million 
Americans are affected each year, and estimates of deaths due to sepsis range from 10-
60% of those affected.
1
 Sepsis is the leading cause of death in hospitals; however, recent 
polls indicate that only half of adults know what sepsis is.
2
 Among patients receiving care 
in the intensive care unit (ICU), sepsis is the leading non-cardiac cause of death.
3–5
 In 
addition to the significant impact on human life, sepsis costs the US healthcare system an 
estimated 14.6 billion dollars in 2008, making it one of the most expensive diseases to 
treat.
6
 
Consensus clinical definitions for sepsis, severe sepsis, and septic shock have 
been updated repeatedly to define more relevant clinical groups.
7–9
  According to the 
2003 consensus definition, sepsis is the presence of an infection along with 2 or more of 
these physiological markers of the systemic inflammatory response syndrome (SIRS): 
Temperature >38.3 degrees Celsius or <36 degrees Celsius, heart rate >90 beats per 
minute, respiratory rate >20 breaths per minute, white blood cell count >12,000 microL
-1
 
or <4,000 microL
-1 
or greater than 10% immature white blood cell forms (bandemia). 
Severe sepsis is defined as the presence of sepsis with sepsis-induced tissue or organ 
dysfunction. Septic shock is defined as fluid-unresponsive sepsis-induced hypotension, 
and is a form of distributive shock often associated with elevated serum lactate >4 mg/dl, 
a marker of tissue hypoperfusion.
8
 The 2016 update of the clinical definition of sepsis, 
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and its reliance on the Sequential/Sepsis-related Organ Failure Assessment Score (SOFA) 
in the ICU and quick SOFA (qSOFA)in other hospital and pre-hospital settings
10,11
, are 
subject to ongoing debate in the emergency and critical care medicine communities as to 
the new definition’s validity and usefulness.12,13 In this new paradigm, severe sepsis has 
been rebranded as sepsis and the SIRS criteria have been discarded. Although the ICD-
9CM and ICD-10 code definitions have not yet been changed to reflect the new criteria, 
these shifts in definition will likely complicate research using data collected after the 
release of the new definitions. The new sepsis definitions, when applied to study 
populations will engender a group of research findings that are not comparable to prior 
studies. These changes may create difficulties placing study findings in context and better 
understanding how to identify, treat, and plan for long-term care of patients facing sepsis 
in the hospital and living with its aftermath. Research conducted with data collected prior 
to the 2016 changes widely uses the standard definitions of sepsis from the 2003 
consensus definitions.  
   Controversy surrounding sepsis is not limited to how this disease should be 
defined. Treatment of patients with sepsis, and in particular the multi-step standardized 
protocols of care for patients with sepsis has undergone many trials and failed attempts at 
identifying gold standards of treatment.
14–17
 While early empiric antibiotics and fluid 
resuscitation with circulatory support have emerged as the mainstays of treatment, recent 
meta-analyses have put the specific recommendations of a popular protocol (Early Goal-
Directed Therapy) into doubt in favor of less stringent protocols relying on clinician 
gestalt.
18,19
 The list of failed adjunctive therapies for sepsis is too long to enumerate in 
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this dissertation.
20
 Regardless of specific therapies used, the importance of prompt 
intervention is difficult to overstate as mortality has been reported to increase 8% for 
every hour delay of initial treatment inviting comparisons to the concept of a “golden 
hour” for treatment as has been widely accepted by those providing trauma care.21,22 
 Infections of many different types can lead to sepsis. Clinical comorbidities and 
other patient characteristics that create susceptibility to infection often lead to an 
increased chance of progression to sepsis as well. In particular, the very young, very old, 
asplenic, burn, and immunosuppressed (whether through iatrogenic or natural means) 
patients are at particularly high risk of developing infections and subsequent sepsis, 
although sepsis can affect any patient, even those in prior good health.
23
 Though the 
underlying infection leading to sepsis cannot always be identified, the most common 
source of sepsis is a respiratory infection, usually pneumonia, followed by genitourinary 
sources, with other common sources of sepsis including intra-abdominal infection, skin, 
soft tissue, or bone infection, and central nervous system infections also contributing to 
the population of patients with sepsis.
24
 Sepsis can be conceptualized as the interaction of 
pathogen factors, e.g. virulence characteristics of the causative microbe, and  host factors, 
i.e. race, sex, and comorbidity status. Features of individual organ systems, such as the 
relative anatomic protection of the genitourinary system and the tendency of antibiotics to 
concentrate in the genitourinary system, may also differentially impact the body’s 
response to infectious insults.
25
  
Infection source may have an important link to mortality through several 
mechanisms: 1) direct infection-caused organ damage at the site and related organ 
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dysfunction (ex. Pneumonia-related hypoxemia), which could in turn be affected by 
preexisting disease and/or reduced organ reserve related to aging, 2) virulence of the 
pathogens more frequently isolated from that site (ex. Antibiotic-resistant pathogens),
26
 
3) capacity of the organ or anatomic space (ex. abdominal cavity) to contain infection, 
and 4) the capacity of the patient with or without treatment to adapt to the organ failure 
(ex. Immunosuppression), which in turn is related to the role of the organ in supporting 
life. It is also possible that anatomic sources differ in their susceptibility to sepsis induced 
damage related to the release of products of the disordered immune response or the sepsis 
stage at which infection is typically recognized at the affected source organ,
27–30
 or be 
related to organ dysfunction or immune impairment which predisposed to the 
infection.
31,32
 Nevertheless, the current literature is mixed on whether infection source is 
associated with mortality. Some reports confirm an association while others do not, 
suggesting that infection source may not drive mortality once the pathophysiologic 
disarray of sepsis has taken hold.
33
  
With the aging of the US population, the need to understand the unique disease 
patterns and manifestations of illness in the elderly is becoming ever more pressing. 
Older adults may not display the classic symptoms and signs of infections such as fever 
and increased white blood cell count, delaying the recognition and subsequent treatment 
in this group of patients.
34
 Further, older adults have higher comorbidity burdens and less 
physiologic reserve than younger patients, making them more susceptible to poor 
outcomes from critical illness.
35,36
 Additionally, even if older adults survive their initial 
hospitalization, they are at increased risk of readmission and long-term poor outcomes 
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regardless of the initial cause of hospitalization.
37
 Given these concerns, it is especially 
important to understand the epidemiology of sepsis among older adults so that diagnosis 
and treatment can be appropriately tailored and for better prediction of long-term 
functional outcomes.  
Sepsis research is taking place in many settings and many forms ranging from 
basic laboratory studies to quality improvement projects to large scale clinical trials. 
Administrative data provides many benefits that contribute to its utility for understanding 
the epidemiology of sepsis. Administrative datasets are typically large, allowing for a 
bird’s eye view of a patient’s interaction with the healthcare system, and depending on 
the exact data elements included, can provide insight into identification, treatment, and 
management of patients with sepsis. Given that different administrative datasets collect 
information about different groups of people, conduct of multiple observational studies is 
beneficial for replication of findings and understanding the nature of associations that 
may change based on the population studied.
38,39
 
 One distinction made to understand sepsis is the distinction between healthcare 
facility acquired sepsis and community acquired sepsis. Patients developing healthcare 
associated infections and subsequent sepsis are more likely to experience negative 
outcomes owing in part to the more virulent nature of nosocomial pathogens and the 
already weakened host due to the hospital stay.
40,41
 Community-acquired sepsis can be 
approximated using the present-on-admission (POA) flag in administrative datasets 
which was widely implemented following the requirement for its mandate by the Centers 
for Medicare and Medicaid Services (CMS) on October 1, 2008.
42,43
 POA sepsis cases 
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represent a distinct challenge to the healthcare system because they require acute 
healthcare providers in pre-hospital, emergency, and other care delivery settings to 
rapidly identify patients with sepsis and to initiate treatment. The CDC has also instituted 
a campaign encouraging patients to self-advocate if they suspect sepsis. These POA 
sepsis cases represent multiple opportunities for early intervention to reduce poor 
outcomes. Elucidating the epidemiology of POA sepsis may contribute to improvements 
in sepsis recognition, management, and treatment in the emergency department and 
during the initial hours following hospital admission regardless of care setting. 
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Specific Aims 
This dissertation explores underlying epidemiologic patterns related to sepsis 
mortality and readmissions. This work was undertaken to: 1) clarify risk factors for in-
hospital mortality from sepsis with regards to the initial infection source, 2) understand 
broader temporal trends of diagnosis and sepsis fatalities, and 3) understand the nature of 
patients hospitalized with sepsis more than once in a 30-day period. 
 
Aim 1. Examine relative rates of sepsis mortality for hospitalized patients by initial 
infection source:   
 Examine differences in relative mortality from sepsis by initial infection source 
 Evaluate differences in relative mortality from sepsis by infection source stratified by 
age subgroups  
 Evaluate differences in relative mortality from sepsis by infection source stratified by 
presenting stage of sepsis 
Hypothesis: Patients presenting with sepsis due to genitourinary sources will have lower 
mortality rates than patients presenting with respiratory sources of infection.  
Aim 2. Measure trends in overall and stage-specific in-hospital mortality rates from 
sepsis over time: 
 Characterize patterns and rates of diagnosis of sepsis  
 Examine trends of case fatality rates from sepsis stratified by age subgroups 
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 Examine trends of case fatality rates from sepsis stratified by presenting stage of 
sepsis 
Hypothesis: Case fatality rates will decrease over time while diagnosis rates increase. 
Aim 3. Evaluate predictors of subsequent re-hospitalization for sepsis within 30 days of 
discharge for an intial hospitalization for sepsis: 
 Characterize patients who are re-hospitalized with sepsis within 30 days of an initial 
discharge from a hospitalization for sepsis  
 Characterize associations between features of the index hospitalization and the risk 
for readmission with sepsis 
Hypothesis: Patients with increased comorbidity burden will have a higher risk of 
readmission with sepsis. 
Data Sources 
Aim 1 involved analysis of data from the University HealthSystem Consortium 
(UHC). The UHC is an alliance of academic medical centers in the US dedicated to 
improving quality of care and cost effectiveness, originally formed in 1991.
44
 As of 2015, 
UHC was acquired by Vizient, although UHC has maintained their own name and 
network.
45
 Nearly all of the academic medical centers in the US participate in the UHC 
and data collected includes information from hospitalizations, patient demographics, 
pharmacy records, diagnoses, and procedures. Previous research has validated that UHC 
10 
 
 
achieves high-levels of concordance with patient level individual data from electronic 
medical records.
46
  
Cerner HealthFacts
®
 is a database maintained by the Cerner Corporation (Kansas 
City, MO) with the stated goal of “transforming healthcare by eliminating error, variance 
and waste for healthcare providers and consumers around the world.”47 More than 84 
million patient encounters, 151 million pharmacy orders, and 1.3 billion lab results are 
included in the nearly decade long maintenance of the HealthFacts
®
 database; the validity 
of the HealthFacts database is comparable to other national databases and is considered 
generalizable to the healthcare seeking population of the US.
47,48
  
Significance 
 The work undertaken in this dissertation has significance for clinical providers, 
health services researchers, and policy makers. Understanding the role infection source 
plays with mortality from sepsis could lead to opportunities to refine treatment protocols 
for patients presenting with sepsis by the initial insulting infection source. Further, 
understanding the role of initial insulting infection source may allow for risk adjustment 
tools, such as the commonly used APACHE acuity score, to be calibrated more 
accurately when taking these findings into account.
49
 Description of the temporal trends 
of POA sepsis diagnoses and case fatality rates, especially when viewed in the larger 
context of all sepsis diagnoses and mortality, has important implications for 
understanding the nature of CMS-mandated coding changes and their implementation and 
their impact on care. Ongoing study of temporal trends of mortality from sepsis allows 
clinicians and policymakers the opportunity to perpend the aspects of treatment protocols 
11 
 
 
and recognition programs that may be having the greatest impact on care for patients with 
sepsis. With ongoing scrutiny of costs of care, and the identification of any readmission 
and sepsis itself as a driver of cost, the potential to profoundly influence cost at the 
overlap of sepsis hospitalizations and readmissions is high. With reimbursement penalties 
on the horizon, understanding predictors of readmission is important to hospital systems 
and allow them to appropriately target post-discharge services to those patients at highest 
risk of readmission. Supporting patients with post-discharge care also provides benefit to 
individual patients as additional support after an unanticipated hospitalization may help 
mitigate some of the long term effects of sepsis that lead to poorer quality of life. Overall, 
this dissertation aims to make a significant contribution to understanding the underlying 
epidemiology of sepsis. 
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CHAPTER II 
MORTALITY RATES DIFFER AMONG PATIENTS WITH SEPSIS PRESENT 
ON ADMISSION BY INFECTION SOURCE 
13 
 
 
Abstract 
Objective: The relevance and impact of the initial infection source leading to sepsis has 
been disputed in the literature. This study aims to clarify the role initial infection source 
may have as related to in-hospital mortality for patients with sepsis.  
Methods: We conducted a retrospective cohort study using the University Healthsystem 
Consortium data from 2011-2014. We identified patients with present-on-admission 
sepsis diagnoses using ICD9-CM codes 038, 785.52, 995.1, 995.2 in any position. 
Patients were identified to have respiratory, abdominal, genitourinary, skin, soft tissue, or 
bone infections, or central nervous system infections present at the time of their 
admission to the hospital using ICD9-CM data. Cox proportional hazards models were 
used to estimate hazard rate ratios between infection source and hospital mortality with 
patients with respiratory infections serving as the referent group. Adjusted hazard rate 
ratios were calculated adjusted for age, sex, Charlson-Deyo comorbidity index, 
emergency department admission, and presenting stage of sepsis. Hazard rate ratios were 
also calculated for stratified analyses by age group and presenting stage of sepsis. 
Results: We identified 100,446 patients with sepsis with overall mortality of 18.0%. 
Patients with an initial source of sepsis due to a genitourinary infection experienced 
hospital mortality at a rate 48% lower than patients with sepsis due to a respiratory 
infection (95% CI 0.50-0.55) after adjustment for age, sex, Charlson-Deyo comorbidity 
index, emergency admission, and presenting stage of sepsis. Patients with sepsis from an 
initial source of sepsis due to a skin, soft tissue, or bone infection experienced hospital 
mortality at a rate 47% lower than patients with sepsis due to a respiratory infection after 
14 
 
 
adjustment for age, sex, Charlson-Deyo comorbidity index, emergency admission, and 
presenting stage of sepsis. These relationships persisted in the stratified analyses by age 
and presenting stage of sepsis. 
Conclusion: This study found a consistent association between genitourinary and skin, 
soft tissue, or bone infections and lesser rates of mortality among patients presenting with 
sepsis. This study adds evidence to the role initial infection source plays in outcomes 
from sepsis after controlling for other important risk factors for mortality from sepsis.  
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Introduction 
Sepsis, the immune system’s dysregulated response to an infection, continues to 
have high mortality rates despite ongoing campaigns promoting recognition and 
treatment protocols, and places a high cost burden on the healthcare system.
3,50,51
 
Infections leading to sepsis may start in different organ systems including the lungs, 
genitourinary system, abdomen, or skin and soft tissues. Sepsis mortality may be affected 
by initial source of infection; however, this hypothesis is disputed as others believe that 
the systemic immune response to sepsis leads to mortality independent of the infection 
source.
52,53
 A recent systematic review was unable to form conclusive statements on the 
role of infection source in sepsis mortality due to persistent issues with misclassification 
of infection source, disease heterogeneity, and detailed reporting.
33
  
 Older patients are disproportionately affected by incidence of sepsis and 
mortality from sepsis.
34
 Research studying older adults’ immune response to sepsis has 
revealed differences when compared to younger patients in both human and animal 
research.
54,55
 Older adults may have more susceptibility to infection, and may be less 
likely to have their infections recognized promptly as older patients often do not mount 
stereotypical responses to infection such as fever.
56
 Comorbidities more common among 
the elderly, such as chronic obstructive pulmonary disease and chronic kidney disease, 
likely contribute to both infection susceptibility and sepsis susceptibility, and acute 
management of sepsis may be complicated by these underlying medical conditions.
57
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The objective of this study is to evaluate the role of infection source in mortality 
from sepsis. We hypothesized that mortality differences by infection source would be less 
apparent as patient age increased. We also hypothesized that mortality differences by 
infection source would be minimal among patients presenting with higher acuity sepsis 
disease, e.g. septic shock, at the time of their admission. This study is important as 
increasing pressure is placed on hospitals to evaluate care for patients with sepsis, and 
understanding differences in rates of mortality of sepsis stemming from variable infection 
sources may generate hypotheses for future work developing risk profiles for patients 
with sepsis. 
Methods 
Study Design and Setting 
 We conducted a retrospective cohort study using data extracted from the 
University Healthsystem Consortium Clinical Database/Resource Manager (UHC 
CDBRM) from the first quarter of 2011 through the final quarter of 2014. The UHC 
CDBRM was established in 1984 and is composed of 114 academic medical centers and 
320 affiliated hospitals representing 95% of the academic medical centers in the United 
States and has been validated in prior studies of patients with infectious diseases and 
sepsis.
58–60
 
Eligibility Criteria 
 To be considered for the study, patients must have had a hospital stay during the 
study period, be aged 18 years or older at admission, with a diagnosis of sepsis, severe 
sepsis or septic shock at the time of the hospital admission. Diagnoses of sepsis and 
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septic shock were determined using ICD-9CM codes (038, 785.52, 995.1, 995.2) in any 
position. Timing of diagnosis of cases was determined using UHC’s present-on-
admission (POA) indicator, which has been validated in other infectious diseases.
61
 
Patients with sepsis, severe sepsis, or septic shock who had multiple infection codes 
indicated as POA or no infection code fitting one of the predetermined infection 
categories were excluded from the final analytic sample. Patients with lengths of stay 
longer than 30 days were excluded from the final analytic sample as these patients likely 
experienced events during their hospital course that resulted in poorer outcomes 
disproportionate to most of the patients included in the UHC database. 
Exposure: Infection Classification 
 The conceptual exposure of this study was the initial infection source that led to 
the development of sepsis. ICD-9CM codes (Supplementary Table 2.1) noted as POA 
were used to classfy patients into one of five groups: Respiratory, Abdominal, 
Genitourinary (GU), Skin, soft tissue, and bone (SSTB), and Central nervous system 
(CNS). Respiratory infections were considered the referent group consistent with prior 
literature
53
 as these infections generally make up the preponderance of infections that 
progress to sepsis, severe sepsis, or septic shock.  
Outcome: Time to Hospital Mortality 
 The primary outcome measure was time to in-hospital mortality. Mortality was 
determined by the use of the patient’s discharge status as recorded in the UHC CDBRM, 
and time to hospital mortality was calculated as time of admission with POA sepsis 
subtracted from time of hospital discharge.  
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Potential Confounders 
Comorbidities, age, sex, emergency admission status, year and quarter of hospital 
admission, and presenting stage of sepsis were considered as possible confounders. Race 
and ethnicity designations at the time of hospital admission are known to be 
underestimated and subject to considerable misclassification, therefore we did not 
categorize patients into race or ethnicity categories for this study. Hospital, ICU length of 
stay, and organ dysfunction were reported but not considered as possible confounders 
given that these variables may be part of the causal pathway between initial infection 
source and hospital mortality. Comorbidities were considered using the Charlson-Deyo 
comorbidity index using ICD-9CM codes from the admission for sepsis.
62,63
 Age for 
initial modeling was categorized as 18-54, 55-64, 65-74, 75-84, and 85+ years; the final 
three age categories are consistent with US census categories for the young old, middle 
old, and oldest old. Known differences in outcomes from sepsis according to a patient’s 
sex have been previously observed, with women experiencing disproportionate 
mortality.
64,65
 Patients with sepsis who are admitted through the emergency department 
have been shown to have improved outcomes compared to those patients directly 
admitted to hospital wards.
66,67
 Diagnosis patterns and outcomes for patients with sepsis 
have changed over time.
68–71
 As such, year and quarter of hospital admission were 
considered as potential confounders to account for temporal trends. Presenting stage of 
sepsis was considered as a surrogate for illness severity. If multiple codes for POA sepsis, 
severe sepsis, or septic shock existed, patients were categorized according to the highest 
acuity diagnosis present. 
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Statistical Analyses 
 We summarized patient characteristics by source of infection. Proportions were 
reported for categorical variables, and data were summarized by means and standard 
deviations, or medians and interquartile ranges for normally and non-normally distributed 
continuous variables respectively. Cox proportional hazards models estimated hazard rate 
ratios between infection source and time to in-hospital mortality, adjusted for age, sex, 
Charlson-Deyo comorbidity index, emergency department admission, and presenting 
stage of sepsis. Other covariates were tested for inclusion using a 10% change of estimate 
threshold and evaluated for collinearity by inspection of standard errors and subsequently 
ruled out. Robust sandwich covariance matrix estimates were used to account for 
clustering by hospital. We reported crude hazard rate ratios (HR), adjusted hazard rate 
ratios (AHR), and 95% confidence intervals (CI).  
Stratified Analyses 
 We hypothesized that older patients may have unique responses to specific 
infection sources leading to sepsis. We therefore conducted an additional set of stratified 
analyses dividing the population into the young and middle aged (18-64 years old), the 
young old (65 years-74 years), the middle old (75 years – 84 years), and the oldest old 
(85 years+). Cox proportional hazards models estimated hazard rate ratios within these 
subgroups. Within each strata, patients with respiratory infections remained the referent 
group consistent with the primary analysis. 
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Others have hypothesized that the initial source of infection does not affect 
outcomes once the physiologic disarray from septic shock has taken effect. Therefore, we 
pre-specified stratified analyses by presenting stage of sepsis to evaluate whether there 
were differences in outcomes among patients who presented with different initial 
infections at any level of acuity. 
 Finally, we conducted an analysis limiting follow-up time to 48 hours. The 
purpse of this analysis was to: 1) clarify associations among a subgroup of patients whose 
death was almost certainly due to their disease present at the time of admission, 2) 
determine if associations were similar among patients experiencing mortality early, and 
3) understand if there is a group of patients with such severe disease at the time of 
presentation that no intervention was likely to change the disease progression. 
Ethical Considerations 
This research was approved by the University of Massachusetts Institutional Review 
Board; the informed consent requirement was waived.  
Results 
From 2011-2014, there were 330,304 adult inpatient encounters in the UHC 
database with a diagnosis of sepsis, severe sepsis, or septic shock. Of these encounters, 
237,045 had a sepsis diagnosis present on admission to the hospital, representing 189,636 
unique patients. We excluded 15,414 patients with lengths of stay greater than 30 days. 
We excluded 73,776 patients with multiple infections present-on-admission or with 
sepsis diagnoses without a POA infection recorded or an infection not fitting into one of 
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the five exposure categories resulting in an analytic sample of 100,446 patients. (Figure 
2.1) 
 Among all patients with sepsis included in this study, 34.0% were identified as 
having a respiratory infection, 16.9% were identified as having an abdominal infection, 
36.4% were identified as having a GU infection, 11.9% as having a SSTB infection, and 
0.9% were identified as having a CNS infection. Patients presenting with respiratory or 
GU infections were more often older than age 85 than in cases of other infections. The 
majority of patients presenting with CNS infections were younger than patients 
presenting with other types of infections, with most (68%) being under age 65. Women 
generally accounted for less than half of the patients presenting with any infection, with 
the exception of GU infections. Patients presenting with a CNS infection had longer ICU 
lengths of stay than patients presenting with other infections; however their median 
hospital length of stay was not generally different from patients presenting with other 
infections. (Table 2.1)  
 Overall hospital mortality in this study was 16.1%. Compared to patients with 
respiratory infections, our referent group, patients with GU or SSTB infections had 
approximately half the risk of death while in the hospital after adjustment for age, sex, 
ED admission, Charlson-Deyo comorbidity status, and presenting stage of sepsis. (GU: 
AHR: 0.52 95%CI 0.50-0.55 p<0.0001; SSTB: AHR: 0.53 95%CI: 0.49-0.57 p<0.0001) 
Patients with abdominal or CNS infections had approximately the same rate of death 
compared to patients with respiratory infections after adjustment for age, sex, ED 
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admission, Charlson-Deyo comorbidity status, and presenting stage of sepsis 
(Abdominal: AHR: 0.99 95%CI 0.95-1.03 p=0.4751; CNS: AHR: 1.10 95%CI 0.94-1.27 
p=0.2388). (Figure 2.2,Table 2.2) 
Results Stratified by Age Group 
 When stratified by age group, most characteristics were evenly distributed. 
Almost 90% of the oldest old were admitted through the emergency department. 
Regardless of age group, patients had a moderate level of comorbidity burden. Length of 
stay was generally similar amongst age groups, although both ICU and hospital length of 
stay were somewhat shorter among the oldest old patients, possibly due to early death 
among this age group. (Supplementary Table 2.2) 
An  increase in mortality was observed among age subgroups with 14.3% 
observed mortality in the young and middle aged, 17.3% mortality in the young old, 
17.8% mortality in the middle old, and 25.7% mortality in the oldest old. (Figure 2.2) 
Among the group of patients under age 65, patients who initially presented to the hospital 
with a GU or SSTB infection had lower rates of mortality compared to patients who 
initially presented to the hospital with a respiratory infection. (GU: AHR: 0.49 95%CI 
0.45-0.53 p<0.0001; SSTB: AHR: 0.48 95%CI: 0.44-0.52 p<0.0001) Among the group of 
patients under age 65, those presenting with CNS infections had higher rates of mortality 
relative to patients under 65 initially presenting with a CNS infection (AHR: 1.29 95%CI 
1.07-1.55 p=0.0072). Patients under age 65 who presented with an abdominal infection 
had comparable rates of mortality compared to patients who presented with a respiratory 
23 
 
 
infection. (AHR: 1.01 95%CI 0.95-1.07 p=0.7064) (Figure 2.5A, Supplementary Table 
2.3) Among patients 65-74, those presenting with GU or SSTB infections continued to 
have lower rates of mortality compared to those patients age 65-74 presenting with 
respiratory infections. (GU: AHR: 0.51 95%CI 0.47-0.55 p<0.0001; SSTB: AHR:0.53 
95%CI: 0.47-0.59 p<0.0001) Among those aged 65-74, patients presenting with 
abdominal infections also had lower rates of mortality compared to patients aged 65-74 
presenting with respiratory infections (AHR: 0.81 95%CI 0.73-0.89 p<0.0001). For 
patients aged 65-74, those presenting with CNS infections did not have notably different 
rates of mortality compared to those presenting with respiratory infections. (AHR: 0.85, 
95%CI 0.61-1.19 p=0.3426)  (Figure 2.5B, Supplementary Table 2.4) For patients aged 
75-84, these overall relationships of lower mortality rates for those presenting with GU, 
SSTB, and abdominal infections compared to those presenting with respiratory infections 
remained consistent. For patients aged 75-84, those presenting with CNS infections did 
not have mortality rates differing from those presenting with respiratory infections. 
(AHR: 0.87 95% CI 0.60-1.26 p=0.4602) (Figure 2.5C, Supplementary Table 2.5) 
Among the oldest old, those presenting with GU, SSTB, or abdominal infections had 
lower rates of mortality compared to those presenting with respiratory infections, 
although this relationship was less pronounced among this age group for those presenting 
with SSTB infections. (AHR: 0.74, 95%CI 0.62-0.87, p=0.0004) (Figure 2.5D, 
Supplementary Table 2.6) 
Results Stratified by Presenting Stage of Sepsis 
24 
 
 
 An expected increase in mortality was observed as the severity of the presenting 
stage of sepsis increased, with 5.3% mortality in those presenting with sepsis, 12.8% 
mortality in those presenting with severe sepsis, and 26.3% mortality among those 
presenting with septic shock. (Figure 2.3) For those patients presenting with sepsis and a 
GU or SSTB infection, lower rates of mortality were observed compared to those 
presenting with sepsis and a respiratory infection. (GU: AHR: 0.41 95%CI 0.36-0.45 
p<0.0001; SSTB: AHR: 0.30 95% CI: 0.25-0.36 p<0.0001) Among those patients 
presenting with sepsis and an abdominal infection, there were also relatively lower rates 
of mortality compared to those presenting with sepsis and a respiratory infection. (AHR: 
0.80 95% CI 0.70-0.91 p=0.0007) For those patients presenting with sepsis and a CNS 
infection, rates of mortality were not significantly different than for those patients 
presenting with sepsis and a respiratory infection. (AHR: 1.26 95%CI 0.89-1.79 
p=0.1932) (Figure 2.6A, Supplementary Table 2.7)  Among patients presenting with 
severe sepsis and a GU or SSTB infection, rates of mortality continued to be lower than 
for those patients presenting with severe sepsis and a respiratory infection. (GU: AHR: 
0.48 95% CI 0.44-0.53 p<0.0001; SSTB: AHR: 0.41 95% CI: 0.35-0.47 p<0.0001) For 
those patients presenting with severe sepsis and a CNS infection, there were also lower 
rates of mortality compared to those patients presenting with severe sepsis and a 
respiratory infection (AHR: 0.74 95% CI 0.54-1.00, p=0.0493); however, this estimate is 
less stable as relatively few patients present with severe sepsis and a CNS infection. 
Among those patients presenting with severe sepsis and an abdominal infection, there 
were not statistically significant differences in time to mortality compared to those 
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patients presenting with severe sepsis and a respiratory infection. (AHR: 1.03 95% CI 
0.93-1.15 p=0.5414) (Figure 2.6B, Supplementary Table 2.8) Among patients presenting 
with septic shock, those with either a GU or SSTB infection had lower rates of mortality 
than those presenting with septic shock and a respiratory infection  (GU: AHR: 0.57 95% 
CI 0.54-0.61 p<0.0001; SSTB: AHR: 0.63 95% CI 0.58-0.68 p<0.0001) Among patients 
presenting with septic shock and an abdominal or CNS infection, there were not 
statistically significant differences in rates of mortality when compared to those 
presenting with septic shock and a respiratory infection. (Abdominal: AHR: 1.00 95% CI 
0.96-1.05 p=0.9554; CNS: AHR: 1.18 95%CI 0.98-1.42 p=0.790) (Figure 2.6C, 
Supplementary Table 2.9) 
 Outcomes Limited to 48 Hours  
Overall hospital mortality at 48 hours was 5.3%. When limited to 48 hours of 
follow-up time, patients presenting with SSTB infections had lower rates of 48-hour 
mortality compared to patients presenting with respiratory infections (AHR: 0.61 95%CI 
0.54-0.68 p<0.0001). Notably, patients presenting with CNS infections had a higher rate 
of mortality compared to patients presenting with respiratory infections when limited to 
48 hours of follow-up time (AHR: 1.28 95% CI 1.00-1.65 p=0.0506). (Table 2.3) 
Discussion 
This study found an association between the initial presenting source of infection 
and rates of in-hospital mortality from sepsis. Initial presentation of patients with sepsis 
due to a GU or SSTB infection was associated with a lower rate of in-hospital mortality 
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when compared to patients initially presenting with sepsis due to respiratory infections 
among hospitalized patients, and within subgroups of hospitalized patients. For patients 
presenting with sepsis due to an abdominal infection, there were not appreciable 
differences in the rate of in-hospital mortality across all hospitalized patients included in 
the study when compared to those patients presenting with sepsis due to a respiratory 
infection.  
 This study found greater mortality among patients presenting with more severe 
forms of sepsis spectrum disease, regardless of the presenting type of infection. There 
was also greater mortality with increased age regardless of the presenting type of 
infection, consistent with existing literature that older patients have a lessened ability to 
withstand the physiologic onslaught of infection and immune disarray from sepsis.
34
 
However, while observed mortality was greater with both advancing age and severity of 
presenting illness, there remained a strong, consistent association of presentation with 
GU or SSTB infection and rates of in-hospital mortality when compared to patients 
presenting with respiratory infection consistently observed within age and presenting 
stage of sepsis strata; however, despite these somewhat encouraging findings, there 
remain opportunities for improvement of care. 
 Our study’s findings are consistent with other research in this area. Our previous 
systematic review found support for lower in-hospital mortality among patients with GU 
or SSTB infections.
33
 Other studies have also found decreased mortality risk among 
patients presenting with GU infections, although these studies have been limited to 
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patients with severe sepsis or septic shock or to the ICU setting.
53,72
 This study did not 
find evidence to support previous studies’ assertions that abdominal infections portend 
worse outcomes for patients with sepsis.
53
 Possible explanations for this finding may be 
due to the groupings of abdominal infections which represent considerable heterogeneity 
of infections and pathogens or demographics of different patients with abdominal 
infections. Another possible explanation is that patients with more severe illness, 
regardless of the source of sepsis, may present with such profound immune dysregulation 
that the underlying cause is less important than the rectification of the manifestations of 
disease. At least one other study has also shown a lack of difference in mortality based on 
initial infection source, positing that the primary driver of mortality is related to the organ 
dysfunction and the efficacy of resuscitation in septic shock.
52
  
 The consistent association between GU infections and lower in-hospital mortality 
suggest that there may be unique characteristics of this patient group that has important 
implications for future research design as well as clinical care. Potential explanations for 
this mortality benefit may include the amenability of these infections to source control 
interventions, the relatively protected anatomic site due to the barrier functions of the GU 
system, and a tendency for antibiotics to concentrate within the GU system.
25,73
 The 
association with lesser mortality compared to patients with respiratory infections suggest 
that protocols emphasizing prompt identification, rapid source control, and appropriate 
antimicrobial use have been successful.
74
 Nevertheless, it remains possible that absolute 
mortality could still be improved with identification of at-risk patients in the community 
setting and curative management for GU infections prior to progression to sepsis and 
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prevent other serious consequences of severe infection and sepsis such as lasting end-
organ damage.
75
  
 This study also found a consistent association between SSTB infections and lower 
in-hospital mortality compared to patients with respiratory infections, a finding which 
was somewhat attenuated in the oldest old. This finding may be due to increased 
breakdown in the skin in older adults and increased seriousness of skin infections in this 
group due to additional comorbidities or particular conditions such as pressure ulcers.
76,77
 
We speculate that there may also be a delay in diagnosis due to skin and soft tissue 
infections that are not readily visible and may not be rapidly recognized, particularly in 
these oldest patients who are more likely to have limited mobility.
78
 This relative 
increased mortality also suggests that the oldest old patients may have a decreased ability 
to heal relatively superficial wounds resulting in increased likelihood of progressive 
infection.
34,79
 These findings suggest that efforts to monitor skin breakdown in the 
elderly, particularly in high risk settings such as skilled nursing facilities are warranted 
and may have mortality benefits in addition to improving quality of life when pressure 
ulcers and other painful skin infections are identified early.
78,80
 These findings potentially 
offer opportunities for care improvement and cost efficiency. 
 This study has important limitations. First, despite extensive cross-checking of 
lists it is possible that misclassification of the exposure occurred due to infections not 
being properly recorded or due to sepsis not being due to the infection recorded at 
admission. While we attempted to ensure that sepsis was due to the presenting infection 
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by requiring that both a sepsis code and an infection code were present on admission, this 
may have been imperfect and some cases of sepsis may have been due to other causes of 
infection rather than those recorded at admission. Conversely, patients admitted with an 
infection may have developed sepsis after their admission but not had their sepsis 
documented, and this sepsis would have not been detected in our study. We lacked true 
cause of death data; however, we attempted to limit the effects of other possible hospital 
sequelae by limiting the analysis to those with lengths of stay less than 30 days, and 
performing an additional subgroup analysis limiting the follow-up of the population to 48 
hours. It is assumed that these early deaths are likely due to the continuation of the sepsis 
process at admission. Finally, this study includes only academic medical centers and their 
affiliated hospitals, limiting generalizability to other settings.  Despite these limitations, 
the association between certain infections and mortality is strong and indicates that 
anatomic source of infection should be considered in other studies of sepsis, and offer an 
opportunity for tailoring of care.  
 This study adds to the existing literature on the role of initial infection source as it 
relates to sepsis mortality. Where randomized clinical trials are ethically and logistically 
impossible, observational studies are needed to further our understanding of the 
epidemiology of sepsis spectrum disease and the role of the initial infection source. This 
study suggests that risk stratification of patients is possible and perhaps necessary based 
on the initial infection source. Such approaches may have increasing relevance as sepsis 
comes under increasing scrutiny by those interested in hospital payments, as well as 
having important clinical implications. 
 
 
 
Table 2.1: Baseline Demographics and Clinical Characteristics of Patients with Sepsis Present-on-Admission by Infection 
Source 
 
 
  Characteristic 
 Respiratory 
Infection 
(n=34,117) 
Abdominal 
Infection 
(n=16,982) 
Genitourinary 
Infection 
(n=36,524) 
Skin, Soft 
Tissue, and 
Bone Infection 
(n=11,937) 
CNS 
Infection 
(n=886) 
   Percentage    
Age (Years) 18-54 27.6 32.8 22.4 38.5 43.5 
 55-64 22.2 27.0 18.0 25.2 24.5 
 65-74 22.3 21.0 20.9 18.6 18.1 
 75-84 16.9 12.9 21.9 11.6 11.0 
 85+ 11.0 6.3 16.8 6.1 3.1 
Women  41.8 43.1 56.5 38.1 42.4 
Length of Stay (Days) Median (Interquartile Range)  
Total 7.0  
(4.0-13.0) 
8.0  
(4.0-14.0) 
6.0  
(4.0-9.0) 
9.0  
(5.0-15.0) 
9.0  
(5.0-15.0) 
ICU 2.0  
(0.0-6.0) 
2.0  
(0.0-6.0) 
0.0  
(0.0-3.0) 
1.0  
(0.0-4.0) 
3.0  
(1.0-7.0) 
Emergency Department Admission 74.2 66.1 82.2 75.4 66.9 
Severity Indices & Clinical 
Comorbidities 
  
 Charlson-Deyo 
Comorbidity 
Score 
     
 0 16.8 13.1 18.2 16.8 26.6 
 1-3 51.0 34.0 53.4 48.2 52.9 
 4+ 32.3 52.9 28.4 35.0 20.4 
Year of Hospital 
Admission 
2011 17.8 18.6 18.6 16.7 20.2 
 2012 21.4 22.3 21.9 21.3 20.9 
 2013 27.0 25.9 25.7 26.8 27.5 
3
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 2014 33.8 33.3 33.8 35.2 31.4 
Quarter of 
Hospital 
Admission 
First 28.5 23.9 23.1 22.6 24.6 
 Second 24.0 23.8 24.1 24.8 25.5 
 Third 20.5 24.9 25.3 25.1 23.1 
 Fourth 27.0 27.4 27.5 27.5 26.8 
Presenting Stage 
of Sepsis 
Sepsis 27.7 25.3 38.3 39.8 35.8 
 Severe Sepsis 25.0 20.8 26.5 24.6 30.4 
 Septic Shock 47.3 54.0 35.3 35.6 33.9 
Organ 
Dysfunction 
      
 Cardiovascular 54.2 60.3 43.6 42.4 37.5 
 Hematologic 18.9 31.2 18.1 17.3 21.4 
 Hepatic 5.1 9.5 2.8 2.7 3.6 
 Neurologic 15.4 10.4 18.7 11.1 34.4 
 Renal 52.4 56.7 65.3 53.8 34.9 
 Respiratory 54.5 24.2 17.7 17.1 38.4 
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Table 2.2: Effect Estimates of Hospital Mortality by Infection Source for Patients with Sepsis, Severe Sepsis, or Septic Shock 
  Number 
of 
Deaths 
Person-days Mortality Rate 
 per 1,000 person-days 
Mortality  
(%) 
Crude Hazard Rate 
Ratio                             
(95% Confidence 
Interval, p-value) 
Adjusted Hazard 
Rate Ratio*             
(95% Confidence 
Interval, p-value) 
Respiratory 
Infection 
(n=34,117) 
7,254 312,212 9.2 21.3 Referent 
Abdominal 
Infection  
(n=16,982) 
4,175 169,786 10.0 24.6 1.06 (1.01-1.11, 
p=0.0082) 
0.99 (0.95-1.03, 
p=0.4751) 
Genitourinary 
Infection 
(n=36,524) 
3,299 276,355 7.6  9.0 0.51 (0.48-0.54, 
p<0.0001) 
0.52 (0.50-0.55, 
p<0.0001) 
Skin, Soft Tissue, 
and Bone Infection 
(n=11,937) 
1,259 125,273 10.5 10.6 0.44 (0.41-0.47, 
p<0.0001) 
0.53 (0.49-0.57, 
p<0.0001) 
CNS Infection 
(n=886) 
175 9,792 11.1 19.8 0.79 (0.68-0.91, 
p=0.0016) 
1.10 (0.94-1.27, 
p=0.2388) 
* Adjusted for age, sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis 
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Table 2.3: Effect Estimates of Hospital Mortality by Infection Source for Patients with Sepsis Limited to 48 Hours of Follow-
up Time  
 Number 
of 
Deaths 
Person
-days 
Mortality 
Rate 
(per 1,000 
person-
days) 
Mortality 
(%) 
Crude Hazard Rate Ratio                             
(95% Confidence Interval, p-value) 
Adjusted Hazard Rate Ratio*             
(95% Confidence Interval, p-value) 
Respiratory 
Infection 
(n=34,117) 
2,398 65,624 1.9 7.0 Referent 
Abdominal 
Infection  
(n=16,982) 
1,369 32,620 1.9 8.1 1.15 (1.06-1.24, p=0.0005) 1.09 (1.02-1.17, p=0.0144) 
Genitourinary 
Infection 
(n=36,524) 
1,118 71,371 2.0 3.1 0.43 (0.40-0.47, p<0.0001) 0.48 (0.45-0.52, p<0.0001) 
Skin, Soft 
Tissue, and 
Bone Infection 
(n=11,937) 
397 23,403 2.0 3.3 0.47 (0.41-0.53, p<0.0001) 0.61 (0.54-0.68, p<0.0001) 
CNS Infection 
(n=886) 
56 1,715 1.9 6.3 0.90 (0.68-1.18, p=0.4248) 1.28 (1.00-1.65, p=0.0506) 
* Adjusted for age, sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis
3
3
 
34 
 
 
Figure 2.1 Selection of Participants 
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Unique Patients
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Figure 2.2 Percent Mortality by Initial Infection Source by Age Strata: <65, 65-74, 75-84, 85+
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Figure 2.3 Percent Mortality by Initial Infection Source by Presenting Stage of Sepsis: Sepsis, Severe Sepsis, Septic Shock  
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Figure 2.4 Kaplan-Meier Survival Curves of In-hospital Mortality by Initial Infection Source
 
 
  
CNS
SSTB
GU
RESP
ABD
3
7
 
 
 
 
Figure 2.5a Effect Estimates of Time to Hospital Mortality for Patients under Age 65 Adjusted for Sex, Charlson-Deyo 
Comorbidity Index, Emergency Admission, and Presenting Stage of Sepsis  
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Figure 2.5b Effect Estimates of Time to Hospital Mortality for Patients Age 65-74 Adjusted for Sex, Charlson-Deyo 
Comorbidity Index, Emergency Admission, and Presenting Stage of Sepsis  
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Figure 2.5c Effect Estimates of Time to Hospital Mortality for Patients Age 75-84 Adjusted for Sex, Charlson-Deyo 
Comorbidity Index, Emergency Admission, and Presenting Stage of Sepsis 
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Figure 2.5d Effect Estimates of Time to Hospital Mortality for Patients Age 85+ Adjusted for Sex, Charlson-Deyo 
Comorbidity Index, Emergency Admission, and Presenting Stage of Sepsis  
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Figure 2.6a Effect Estimates of Time to Hospital Mortality for Patients Presenting with Sepsis Adjusted for Sex, Charlson-
Deyo Comorbidity Index, Emergency Admission, and Age  
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Figure 2.6b Effect Estimates of Time to Hospital Mortality for Patients Presenting with Severe Sepsis Adjusted for Sex, 
Charlson-Deyo Comorbidity Index, Emergency Admission, and Age  
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Figure 2.6c Effect Estimates of Time to Hospital Mortality for Patients Presenting with Septic Shock Adjusted for Sex, 
Charlson-Deyo Comorbidity Index, Emergency Admission, and Age  
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Supplementary Table 2.1: ICD-9 CM Codes Used to Identify Sepsis, Infection Source, 
and Organ Dysfunction Categories  
 ICD-9CM Codes 
Sepsis 995.91, 038  
Severe Sepsis  995.92 
Septic Shock 785.5 
Respiratory Infections 010, 011, 012, 013, 014, 015, 016, 017, 018, 032, 033, 
034, 461, 462, 463, 464, 465, 480, 481, 482, 483, 484, 
485, 486, 491.21 
Abdominal Infections 001, 002, 003, 004, 005, 008, 0845, 009, 540, 541, 542, 
543.9, 562.01, 563.203, 562.11, 562.13, 566, 567, 569.5, 
569.61, 569.71, 569.83, 572, 575 
Genitourinary Infections 590, 595, 597, 598, 599, 601, 604, 614, 615, 616 
Skin, Soft Tissue, and Bone 
Infections 
451, 680, 681, 682, 683, 686, 711, 728.86, 730, 785.4 
Central Nervous System Infections 036, 090, 320, 322, 324, 325 
Cardiovascular Failure 375, 376.6, 458, 785.5 
Hematologic Failure 286.6, 286.9, 287.4, 287.5 
Hepatic Failure 570, 573.4 
Neurologic Failure 293, 348.1, 348.3 
Renal Failure 584 
Respiratory Failure 335, 518.8, 786.03, 799.1, 967  
 
 
 
Supplementary Table 2.2: Baseline Demographics and Clinical Characteristics of Patients with Sepsis Present-On-Admission 
by Infection Source and Age Category 
 
 
  Characteristic 
 Respiratory 
Infection 
 
Abdominal 
Infection 
 
Genitourinary 
Infection 
 
Skin, Soft 
Tissue, and 
Bone Infection 
 
CNS 
Infection 
 
 Age (Years)  Percentage    
Women <65 41.2 40.9 60.9 36.1 40.9 
 65-74 40.0 42.2 50.6 37.3 43.1 
 75-84 41.6 47.1 51.9 41.7 46.4 
 85+ 48.9 59.5 59.4 55.0 59.3 
Length of Stay (Days) Median (Interquartile Range)  
Total <65 8.0  
(4.0-14.0) 
8.0  
(4.0-15.0) 
6.0  
(3.0-10.0) 
9.0  
(5.0-15.0) 
9.0  
(5.0-15.0) 
 65-74 8.0  
(4.0-13.0) 
8.0  
(4.0-14.0) 
6.0  
(4.0-10.0) 
9.0  
(5.0-15.0) 
11.0  
(5.5-16.0) 
 75-84 7.0  
(4.0-12.0) 
8.0  
(4.0-14.0) 
6.0  
(4.0-10.0) 
8.0  
(5.0-14.0) 
9.0  
(5.0-15.0) 
 85+ 6.0  
(3.0-10.0) 
7.0  
(4.0-12.0) 
6.0  
(4.0-9.0) 
7.0  
(4.0-11.0) 
10.0  
(6.0-13.0) 
ICU <65 3.0  
(0.0-7.0) 
2.0  
(0.0-6.0) 
1.0  
(0.0-3.0) 
1.0  
(0.0-4.0) 
3.0  
(1.0-8.0) 
 65-74 2.0  
(0.0-7.0) 
2.0  
(0.0-6.0) 
1.0  
(0.0-3.0) 
1.0  
(0.0-4.0) 
4.0  
(1.0-8.0) 
 75-84 2.0  
(0.0-6.0) 
2.0  
(0.0-6.0) 
0.0  
(0.0-3.0) 
1.0  
(0.0-4.0) 
3.0  
(1.0-7.0) 
 85+ 1.0  
(0.0-3.0) 
1.0  
(0.0-4.0) 
0.0  
(0.0-2.0) 
0.0  
(0.0-2.0) 
2.0  
(0.0-4.0) 
Emergency 
Department 
Admission 
<65 70.8 63.5 79.3 75.0 66.8 
 65-74 72.2 64.7 79.6 73.3 63.1 
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 75-84 77.7 72.3 83.7 75.2 67.0 
 85+ 88.2 83.0 90.6 85.0 92.6 
Charlson-Deyo 
Comorbidity 
Score 
      
0 <65 22.3 14.1 25.0 20.6 30.2 
 65-74 11.5 10.5 14.4 10.3 16.9 
 75-84 10.1 12.1 12.7 9.4 20.6 
 85+ 12.7 14.7 13.7 11.7 25.9 
1-3 <65 49.1 27.8 50.8 48.1 51.2 
 65-74 50.0 37.2 52.3 45.8 58.8 
 75-84 53.0 46.4 54.4 47.9 51.6 
 85+ 58.2 56.6 59.6 57.3 63.0 
4+ <65 28.6 58.1 24.2 31.4 18.6 
 65-74 38.6 52.3 33.4 44.0 24.4 
 75-84 37.0 41.6 32.8 42.7 27.8 
 85+ 29.1 28.6 26.7 31.0 11.1 
Year of 
Hospital 
Admission 
      
2011 <65 18.5 18.5 18.3 16.6 19.9 
 65-74 16.7 18.1 18.0 17.4 21.9 
 75-84 17.7 19.6 19.1 17.6 21.7 
 85+ 17.2 19.3 19.2 14.5 11.1 
2012 <65 21.5 23.0 22.1 21.2 21.4 
 65-74 20.9 20.5 20.7 20.4 16.9 
 75-84 21.5 21.8 22.1 22.7 18.6 
 85+ 21.8 22.4 22.9 21.6 40.7 
2013 <65 26.5 25.6 25.3 26.8 27.6 
4
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 65-74 27.9 26.4 26.0 26.1 25.0 
 75-84 26.7 26.3 26.0 26.4 34.0 
 85+ 27.7 25.7 25.6 29.3 18.5 
2014 <65 33.4 32.9 34.3 35.4 31.1 
 65-74 34.5 35.0 35.3 36.1 36.3 
 75-84 34.1 32.4 32.9 33.3 25.8 
 85+ 33.4 32.7 32.3 34.6 29.6 
Quarter of 
Hospital 
Admission 
      
First <65 28.8 23.7 22.6 22.8 25.9 
 65-74 27.8 24.4 22.8 21.8 16.9 
 75-84 28.0 23.2 22.9 22.2 25.8 
 85+ 29.6 25.8 25.2 23.8 37.0 
Second <65 24.1 23.9 24.8 24.9 25.6 
 65-74 24.3 22.9 23.5 24.3 25.6 
 75-84 23.7 25.1 24.1 25.2 24.7 
 85+ 23.2 23.6 23.0 25.3 25.9 
Third <65 20.6 25.2 25.5 25.3 22.6 
 65-74 20.8 24.7 26.1 25.1 27.5 
 75-84 21.0 24.8 25.2 24.5 21.7 
 85+ 18.7 23.2 23.8 24.5 14.8 
Fourth <65 26.6 27.3 27.1 27.0 25.9 
 65-74 27.2 28.1 27.5 28.8 30.0 
 75-84 27.3 26.9 27.8 28.2 27.8 
 85+ 28.5 27.3 28.0 26.3 22.2 
Presenting 
Stage of Sepsis 
      
4
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Sepsis <65 28.0 26.1 38.4 41.0 36.5 
 65-74 26.0 23.7  36.9 37.7 33.1 
 75-84 27.8 23.5 38.5 36.8 38.1 
 85+ 29.6 26.5 39.5 39.7 25.9 
Severe Sepsis  <65 24.1 19.5 25.0 24.2 29.4 
 65-74 24.7 21.0 26.7 24.2 33.1 
 75-84 25.5 23.2 27.4 25.1 28.9 
 85+ 29.0 26.8 28.5 29.3 40.7 
Septic Shock <65 47.9 54.4 36.6 34.8 34.1 
 65-74 49.4 55.3 36.4 38.1 33.8 
 75-84 46.7 53.3 34.1 38.2 33.0 
 85+ 41.3 46.7 32.0 31.0 33.3 
Organ 
Dysfunction 
      
Cardiovascular <65 54.8 61.0 45.8 41.4 37.9 
 65-74 56.1 61.5 44.1 45.1 36.9 
 75-84 53.1 59.5 41.6 44.8 36.1 
 85+ 49.3 51.7 40.6 39.7 37.0 
Hematologic <65 21.0 36.4 20.3 17.1 24.9 
 65-74 18.5 27.9 18.3 18.3 12.5 
 75-84 16.8 21.2 16.4 16.5 17.5 
 85+ 13.4 13.7 14.5 16.5 11.1 
Hepatic <65 6.1 12.6 3.4 2.6 5.0 
 65-74 4.8 7.8 3.1 2.1 1.3 
 75-84 4.1 4.9 2.4 3.0 1.0 
 85+ 3.1 3.1 2.1 0.8 0 
Neurologic <65 13.5 9.4 12.4 8.6 31.7 
4
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 65-74 15.5 10.4 19.0 14.8 41.3 
 75-84 17.3 12.8 23.5 15.8 37.1 
 85+ 21.0 15.6 27.0 17.8 44.4 
Renal <65 49.2 55.9 62.5 53.1 32.9 
 65-74 53.1 58.1 67.0 56.6 32.5 
 75-84 57.4 58.7 66.7 55.4 33.0 
 85+ 59.8 63.3 67.3 58.4 70.4 
Respiratory <65 54.9 25.2 17.0 16.4 39.2 
 65-74 56.3 24.6 19.2 19.3 41.9 
 75-84 53.9 21.5 17.5 18.1 29.9 
 85+ 49.6 19.0 17.4 15.0 29.6 
 
 
 
 
 
 
 
 
 
 
5
0
 
 
 
 
 
Supplementary Table 2.3: Effect Estimates of Hospital Mortality by Infection Source for Patients under Age 65 
  Number 
of Deaths 
Person-
days 
Mortality Rate 
 per 1,000 
person-days 
Mortality 
 (%) 
Crude Hazard 
Rate Ratio                             
(95% Confidence 
Interval, p-value) 
Adjusted 
Hazard Rate 
Ratio*            
(95% 
Confidence 
Interval, p-
value) 
Respiratory Infection 
(n=16,987) 
2,994 163,151 9.6 17.6 Referent 
Abdominal Infection  
(n=10,160) 
2,495 103,440 10.2 24.6 1.31 (1.23-1.40, 
p<0.0001) 
1.01 (0.95-1.07, 
p=0.7064) 
Genitourinary 
Infection 
(n=14,755) 
942 111,699 7.6 6.4 0.45 (0.41-0.49, 
p<0.0001) 
0.49 (0.45-0.53, 
p<0.0001) 
Skin, Soft Tissue, and 
Bone Infection 
(n=7,603) 
622 81,627 10.7 8.2 0.42 (0.39-0.46, 
p<0.0001) 
0.48 (0.44-0.52, 
p<0.0001) 
CNS Infection 
(n=602) 
117 6,635 11.0 19.4 0.98 (0.82-1.17, 
p=0.8010) 
1.29 (1.07-1.55, 
p=0.0072) 
* Adjusted for sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis 
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Supplementary Table 2.4: Effect Estimates of Hospital Mortality by Infection Source for Patients Age 65-74 
  Number 
of 
Deaths 
Person-
days 
Mortality 
Rate (per 
1,000 
person-
days) 
Mortality  
(%) 
Crude Hazard 
Rate Ratio                             
(95% Confidence 
Interval, p-value) 
Adjusted Hazard 
Rate Ratio*             
(95% Confidence 
Interval, p-value) 
Respiratory Infection 
(n=7,607) 
1,791 71,644 9.4 23.5 Referent 
Abdominal Infection  
(n=3,561) 
874 36,094 10.1 24.5 0.97(0.90-1.04, 
p=0.3965) 
0.89 (0.82-0.97, 
p=0.0063) 
Genitourinary 
Infection 
(n=7,631) 
689 59,860 7.8 9.0 0.46 (0.42-0.50, 
p<0.0001) 
0.51 (0.47-0.55, 
p<0.0001) 
Skin, Soft Tissue, and 
Bone Infection 
(n=2,223) 
279 23,805 10.7 12.6 0.47 (0.42-0.53, 
p<0.0001) 
0.53 (0.47-0.59, 
p<0.0001) 
CNS Infection 
(n=160) 
30 1,837 11.5 18.8 0.67 (0.47-0.95, 
p=0.0255) 
0.85 (0.61-1.19, 
p=0.3426) 
* Adjusted for sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis 
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Supplementary Table 2.5: Effect Estimates of Hospital Mortality by Infection Source for Patients Age 75-84 
  Number 
of 
Deaths 
Person
-days 
Mortality 
Rate  (per 
1,000 
person-
days) 
Mortality 
 (%) 
Crude Hazard 
Rate Ratio                             
(95% Confidence 
Interval, p-value) 
Adjusted Hazard 
Rate Ratio*             
(95% Confidence 
Interval, p-value) 
Respiratory Infection 
(n=5,775) 
1,470 49,822 8.6 25.5 
 
Referent 
Abdominal Infection  
(n=2,189) 
527 21,156 9.7 24.1 
 
0.84 (0.77-0.92, 
p=0.0003) 
0.81 (0.73-0.89, 
p<0.0001) 
Genitourinary 
Infection 
(n=7,990) 
866 61,410 7.7 10.8 0.47 (0.43-0.52, 
p<0.0001) 
0.53 (0.48-0.58, 
p<0.0001) 
Skin, Soft Tissue, and 
Bone Infection 
(n=1,385) 
219 13,688 9.9 15.8 0.55 (0.47-0.63, 
p<0.0001) 
0.59 (0.51-0.68, 
p<0.0001) 
CNS Infection 
(n=97) 
23 1,051 10.8 23.7 0.75 (0.52-1.08, 
p=0.1249) 
0.87 (0.60-1.26, 
p=0.4602) 
* Adjusted for sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis 
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Supplementary Table 2.6: Effect Estimates of Hospital Mortality by Infection Source for Patients Age 85+ 
  Number 
of 
Deaths 
Person-days Mortality Rate 
(per 1,000 person-days) 
Mortality 
(%) 
Crude Hazard 
Rate Ratio                             
(95% Confidence 
Interval, p-value) 
Adjusted Hazard 
Rate Ratio*             
(95% Confidence 
Interval, p-value) 
Respiratory 
Infection 
(n=3,748) 
999 27,595 7.4 26.7% Referent 
Abdominal 
Infection  
(n=1,072) 
279 9,096 8.5 26.0% 0.87 (0.77-0.99, 
p=0.0305) 
0.85 (0.75-0.96, 
p=0.0095) 
Genitourinary 
Infection 
(n=6,148) 
802 43,386 7.1 13.0% 0.51 (0.46-0.57, 
p<0.0001) 
0.56 (0.51-0.62, 
p<0.0001) 
Skin, Soft Tissue, 
and Bone Infection 
(n=726) 
139 6,153 8.5 19.2% 0.64 (0.54-0.76, 
p<0.0001) 
0.74 (0.62-0.87, 
p=0.0004) 
CNS Infection 
(n=27) 
5 269 10.0 18.5% 0.55 (0.22-1.35, 
p=0.1896) 
0.57 (0.23-1.42, 
p=0.2291) 
* Adjusted for sex, Charlson-Deyo Comorbidity Index, emergency admission, and presenting stage of sepsis 
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Supplementary Table 2.7: Effect Estimates of Hospital Mortality by Infection Source for Patients Presenting with Sepsis 
  Number 
of 
Deaths 
Person-days Mortality Rate 
(per 1,000 person-days) 
Mortality 
(%) 
Crude Hazard 
Rate Ratio                             
(95% 
Confidence 
Interval, p-
value) 
Adjusted 
Hazard Rate 
Ratio*             
(95% 
Confidence 
Interval, p-
value) 
Respiratory 
Infection 
(n=9,453) 
788 75,539 8.0 8.3% Referent 
Abdominal 
Infection  
(n=4,290) 
368 40,321 9.4 8.6% 0.85 (0.75-0.96, 
p=0.0069) 
0.80 (0.70-0.91 
p=0.0007) 
Genitourinary 
Infection 
(n=13,974) 
406 91,539 6.6 2.9 0.45 (0.40-0.50, 
p<0.0001) 
0.41 (0.36-0.45, 
p<0.0001) 
Skin, Soft Tissue, 
and Bone Infection 
(n=4,753) 
139 46,436 9.8 2.9% 0.28 (0.23-0.34, 
p<0.0001) 
0.30 (0.25-0.36, 
p<0.0001) 
CNS Infection 
(n=317) 
35 3,488 11.0 11.0% 0.95 (0.68-1.32, 
p=0.7434) 
1.26 (0.89-1.79, 
p=0.1932) 
* Adjusted for age, sex, Charlson-Deyo Comorbidity Index, and emergency admission 
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Supplementary Table 2.8: Effect Estimates of Hospital Mortality by Infection Source for Patients Presenting with Severe 
Sepsis 
  Number 
of 
Deaths 
Person-days Mortality Rate 
(per 1,000 person-days) 
Mortality 
(%) 
Crude Hazard 
Rate Ratio                             
(95% 
Confidence 
Interval, p-
value) 
Adjusted 
Hazard Rate 
Ratio*             
(95% 
Confidence 
Interval, p-
value) 
Respiratory 
Infection 
(n=8,530) 
1,469 78,453 9.2 17.2% Referent 
Abdominal 
Infection  
(n=3,527) 
753 36,307 10.3 21.4% 1.09(0.98-1.21, 
p=0.1160) 
1.03 (0.93-1.15, 
p=0.5414) 
Genitourinary 
Infection 
(n=9,675) 
694 72,311 7.5 7.2%  0.53 (0.48-0.58, 
p<0.0001) 
0.48 (0.44-0.53, 
p<0.0001) 
Skin, Soft Tissue, 
and Bone Infection 
(n=2,940) 
237 31,416 10.7 8.1% 0.40 (0.35-0.46, 
p<0.0001) 
0.41 (0.35-0.47, 
p<0.0001) 
CNS Infection 
(n=269) 
39 3,216 12.0 14.5% 0.63 (0.47-0.84, 
p=0.0019) 
0.74 (0.54-1.00, 
p=0.0493) 
* Adjusted for age, sex, Charlson-Deyo Comorbidity Index, and emergency admission 
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Supplementary Table 2.9: Effect Estimates of Hospital Mortality by Infection Source for Patients Presenting with Septic Shock 
  Number 
of 
Deaths 
Person-days Mortality Rate 
(per 1,000 person-days) 
Mortality 
(%) 
Crude Hazard 
Rate Ratio                             
(95% 
Confidence 
Interval, p-
value) 
Adjusted 
Hazard Rate 
Ratio*             
(95% 
Confidence 
Interval, p-
value) 
Respiratory 
Infection 
(n=16,134) 
4,997 158,220 9.8 31.0% Referent 
Abdominal 
Infection  
(n=9,165) 
3,054 93,158 10.2 33.3% 1.04 (0.99-1.09, 
p=0.1149) 
1.00  
(0.96-1.05, 
p=0.9554) 
Genitourinary 
Infection 
(n=12,875) 
2,199 112,505 8.7 17.1% 0.60 (0.57-0.64, 
p<0.0001) 
0.57 (0.54-0.61, 
p<0.0001) 
Skin, Soft Tissue, 
and Bone Infection 
(n=4,244) 
883 47,421 11.2 20.8% 0.60 (0.55-0.66, 
p<0.0001) 
0.63 (0.58-0.68, 
p<0.0001) 
CNS Infection 
(n=300) 
101 3,088 10.3 33.7% 1.05 (0.88-1.26, 
p=0.5810) 
1.18 (0.98-1.42, 
p=0.0790) 
* Adjusted for age, sex, Charlson-Deyo Comorbidity Index, and emergency admission
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CHAPTER III 
RECENT TRENDS IN SEPSIS DIAGNOSIS AND MORTALITY 
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Abstract 
Objective: To highlight recent trends in the reporting of diagnoses and case fatality rates 
of present-on-admission sepsis hospitalizations  
Method: We conducted a retrospective cohort study using Cerner HealthFacts® data 
from October 1, 2008 through June 30, 2014.  ICD-9CM diagnoses and present-on-
admission (POA) notation was used to identify hospitalizations with sepsis, severe sepsis, 
or septic shock and trends in diagnosis and case fatality rates were evaluated.  
Results: At the end of the study period, there was a rate of reported diagnosis for sepsis, 
severe sepsis, or septic shock of 624 per 100,000 hospitalizations and a case fatality rate 
of 10.8%. From the fiscal year beginning October 1, 2008 through June 30, 2014, there 
was a statistically significant decline in the reporting of POA sepsis diagnoses (-
estimate = -104.5, p=0.0051). There was also a statistically significant decrease in case 
fatality rate over the study period (-estimate = -1.77, p=0.0014). 
Conclusions: This study found decreasing trends of POA sepsis in the context of 
increases of overall sepsis diagnosis. A decrease in case fatality rate was also observed, 
possibly representing better care for patients with sepsis or an inflation of denominator 
due to the residual effects of increased numbers of diagnoses, a dispute ongoing in the 
literature. 
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Introduction 
Recent investigations into trends of incidence and mortality from sepsis have been 
limited to academic medical centers
81
, while other investigations of trends in incidence 
and mortality are now outdated or did not consider the full spectrum of disease 
comprising sepsis, severe sepsis, and septic shock.
4,5,69,82–84
  Increased attention to sepsis 
due to educational campaigns
74
 and Centers for Disease Control programs
23
 emphasizing 
patient advocacy directed at asking patients to raise concerns of sepsis and clinician 
awareness have led to a focus on improving recognition and treatment which may affect 
the trends observed among reporting of diagnosis and case fatality rates. Yet, there 
remains disagreement and questions about sepsis diagnosis and fatality rates, and 
variations world-wide.
85
 Additionally, prior work has suggested that the oldest old, who 
make up an increasing proportion of healthcare utilization, may be driving trends upward 
among patients with sepsis, although there may be different patterns of sepsis 
identification and recognition due to physiologic changes leading to different disease 
presentation in this population, rendering evolving disease more difficult to recognize for 
clinicians.
34
  
 In addition to changes in recognition and treatment of sepsis, systematic changes 
in coding practices and variable definitions of severe sepsis in administrative data have 
led to discrepancies in estimates of sepsis incidence and mortality.
86
 Further, the 
implementation of the present-on admission (POA) indicator, resulting in payment 
penalties to hospitals for preventable conditions that were not coded as POA, has led to 
increased attention to sepsis due to community acquired infections.
43
 Hospitalizations 
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with sepsis coded as POA reflect presumably community acquired instances of sepsis and 
present an opportunity for further educational efforts targeted to healthcare consumers 
and practitioners to reduce the burden of disease in the community setting and to focus on 
early identification and swift treatment to intervene before disease progression to organ 
dysfunction with the accompanying higher mortality. 
This paper seeks to understand recent trends in POA sepsis incidence and 
mortality and provide an update to the existing understanding of trends in this disease 
process. This paper additionally seeks to analyze subgroups of patients by age and 
presenting stage of sepsis to determine whether there are differences in trends occurring 
among the oldest, most vulnerable groups of patients affected by sepsis. 
Methods 
Study Design and Setting 
 The HealthFacts® database is maintained by Cerner Corporation (Kansas City, 
MO), one of the largest electronic health record (EHR) vendors in the US. Data is 
contributed by both community and academic hospitals and checked for quality, as well 
as deidentified and made HIPAA compliant. Over 500 hospitals contribute data annually, 
representing 133 million hospital encounters and 84 million unique patients through the 
timespan covered by the database.
48
 HealthFacts contains information about a person’s 
hospital encounter, including diagnoses, demographics, and vital status at discharge.  The 
POA indicator was implemented for all hospital systems nationwide starting on October 
1, 2007. HealthFacts is updated regularly, and at the time of this manuscript, contains 
data through June 30, 2014.  
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Eligibility Criteria 
 To be considered for the study, patients must have had a hospital discharge date 
during the study period (10/1/2008-6/30/2014), be aged 18 years or older at admission, 
and have a diagnosis of sepsis, severe sepsis or septic shock coded as present at the time 
of hospital admission. Diagnoses of sepsis, severe sepsis, and septic shock were 
determined using ICD-9CM codes. (Supplementary Table 3.1) Timing of diagnosis of 
cases was determined using the POA indicator. This method of determining POA status 
has been validated in other infectious processes
61
 and found to be valid and reliable. Only 
encounters from hospitals contributing data to all years in the study period were 
considered eligible, so as to account for potential differences in coding practices at 
different institutions and differences in the case mix of the population at different 
contributing institutions. 
Age Strata 
 Encounters were classified according to age group at the time of admission. Age 
categories were: 18-34, 35-64, 65-74, 75-84, and 85+, with the last three categories 
reflecting the census categorizations of the young old, middle old, and oldest old. 
Statistical Analyses 
 We categorized diagnoses by presenting stage of sepsis and presented changes of 
incidence rates over the years of the study. If multiple ICD-9CM codes were present, 
priority was given to the most severe stage of sepsis coded as POA i.e. if codes for both 
septic shock and severe sepsis were coded as POA, the patient’s encounter would have 
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been classified as presenting with septic shock. Linear regression models were used to 
test for linear trends over time. SAS 9.4 (SAS Institute, Cary, NC) was used for all 
analysis. All rates were calculated to be expressed as per 100,000 hospitalizations. Case 
fatality rates were calculated as the number of deaths divided by the number of sepsis 
diagnoses in a given year; linear regression models were again used to test for trends over 
time.  
An additional sensitivity analysis was performed to investigate trends for sepsis 
that was not indicated as POA to assess this study’s comparability with other studies 
investigating trends of sepsis diagnosed and documented at any point within the hospital 
stay. 
This research was reviewed by the University of Massachusetts Institutional 
Review Board and determined to not be human subjects research.  
Results 
68 hospitals contributed data continuously over each year in the study. Over the 
study period, there were 5,090,729 hospitalizations. (Figure 3.1) Of these 
hospitalizations, 45,581 had a sepsis, severe sepsis, or septic shock diagnosis noted as 
POA. Patients comprising the 18-34 year old age group comprised a relative minority (5-
9%) of all patients admitted to the hospital with sepsis, severe sepsis, or septic shock. The 
majority of hospitalizations presenting with sepsis, severe sepsis, or septic shock were 
among patients aged 35-64 years old, with hospitalizations of patients aged 65-74 or 75-
84 comprising roughly two-fifths of hospitalizations for sepsis, severe sepsis, or septic 
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shock in any given year. The oldest-old patients (aged 85+) comprised 11-17% of 
patients with hospitalizations for sepsis, severe sepsis, or septic shock. Almost two-thirds 
of hospitalizations presented with sepsis, although this does not exclude the possibility 
that these hospitalizations later progressed to severe sepsis or septic shock after 
admission to the hospital. Approximately one-fifth of hospitalizations presented with 
severe sepsis, and approximately 15% presented with septic shock at the time of their 
hospitalization. (Table 3.1) 
 After an initial increase during the first year of the study, decreases in POA 
diagnosis rates over all subsequent years for all presenting stages of sepsis, sepsis, severe 
sepsis, and septic shock were observed. (Figure 3.2) Linear trends were statistically 
significant for all presenting stages of sepsis. (Table 3.2) We noted trends for aggregated 
incidence of hospitalization for a sepsis related diagnosis were similar across age 
categories. We also noted a striking difference and direct relationship in age and the 
incidence of sepsis related hospitalizations. (Figure 3.3) While the overall trends in 
diagnoses were the same, there were differences among the age categories. The lowest 
rates of diagnosis of sepsis over the course of the study were among those aged 18-34 
with rates moving from 269.2 diagnoses per 100,000 hospitalizations to 202.2 diagnoses 
per 100,000 hospitalizations at study end. These lowest rates of diagnosis in the 18-34 
age group also held for severe sepsis (84.0 diagnoses/100,000 hospitalizations for 2008 to 
60.8 diagnoses/100,000 hospitalizations for 2013) and septic shock (50.6 
diagnoses/100,000 hospitalizations for 2008 to 26.9 diagnoses/100,000 hospitalizations 
for 2013). For any given year of the study, rates of diagnosis of sepsis, severe sepsis, or 
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septic shock were similar among patients aged 65-74, 75-84, and 85+. Patients aged 35-
64 had comparable rates of diagnosis of sepsis or severe sepsis to those in older age 
categories, but septic shock diagnoses occurred at rates lower than those in older age 
categories. (Figure 3.3a-c, Supplementary Table 3.2) 
 Overall, absolute case fatality rates decreased by 10.7% for hospitalizations 
presenting with sepsis, 16.6% for severe sepsis, and 19.7% for septic shock. Case fatality 
rates were lowest for patients presenting with sepsis, higher for patients presenting with 
severe sepsis, and higher still for patients presenting with septic shock. (Figure 3.4) In 
general, the highest case fatality rates were observed in hospitalizations for those 85+, but 
this difference was most apparent in hospitalizations for patients presenting with sepsis 
compared to other age groups in those presenting with sepsis. (Figure 3.5) It is worth 
noting that a significant decline in case fatality rates was observed for even the oldest old 
patients for any presenting stage of sepsis. (Supplementary Table 3.2)   
 All sepsis diagnoses, e.g. those that were not limited to those present at the time 
of admission, showed an overall increase, with nearly a 10-fold increase from fiscal year 
2008 to fiscal year 2014. (Supplementary Figure 3.1) There was little variability in the 
total number of overall hospitalizations during this same time period, indicating that the 
denominators for calculating diagnosis rates were similar across years of the study. 
(Supplementary Figure 3.2) 
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Discussion 
 Overall, this study found a significant downward trend of presumably 
community-acquired diagnosis of sepsis, severe sepsis, and septic shock, using the POA 
indicator. This trend was consistent among all age subgroups. We also found a consistent 
downward trend of sepsis-related case fatality rates, even among the oldest old patients 
and most severely ill patients included in the study.  
 The findings of this study add to and support the current literature. There has been 
a documented downward trend in mortality from sepsis regardless of methods of 
evaluating trends.
4,70
 The crude rate of reported sepsis diagnoses was higher in this study 
compared to other studies, although the case fatality rates were comparable, likely due to 
the inclusion of the full spectrum of sepsis diagnoses available.  Like other studies
5,87,88
, 
we did observe a continuing upward trend of all reported sepsis diagnoses; however, we 
found a decrease in reported diagnoses of POA sepsis. Our sensitivity analyses 
documented a trend of increasing diagnoses of all forms of sepsis consistent with prior 
studies. A number of potential explanations exist for these findings. Increased 
recognition, furthered by the efforts of educational outreaches such as the Surviving 
Sepsis Campaign and other organizations, could have led to increased reporting of 
diagnoses. Indeed, the Surviving Sepsis campaign released a major communication in 
2008, temporally associating itself with the requirement of POA coding of diagnoses 
observed in this study.
89
 Differences in coding within administrative databases can also 
lead to discrepancies of reported trends.
90
 There is also the possibility of increased 
incidence of the underlying infections that progress to sepsis, although other 
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investigations have concluded that this is an unlikely explanation.
68
 Further, this study 
focuses on a unique subset of all reported sepsis diagnoses, those diagnoses specifically 
designated as POA, and extends the years under study which raises the possibility of 
trends continuing to change while the practice of POA coding and documentation 
continues to stabilize as it is implemented and standardized.  
 The advent of POA coding has led to increased focus on both the accuracy of 
coding and the impact systematic changes of coding practice have on large scale trends 
across disease processes.
42,91
 However, the consistency of the trends observed from our 
study leads to further speculation about non-systematic factors that may also influence 
trends. Changes of incidence of reporting of sepsis diagnoses are likely related to changes 
of recognition among clinical providers in part due to the myriad of quality improvement 
and other projects dedicated to rapid recognition of the patient with new or evolving 
infection and organ dysfunction.
22
 In addition, there is further investigation warranted 
into the study of clinician patterns of documentation to standardize what appears in the 
electronic medical record and to determine patterns of clinician behavior. 
Our study found decreases of sepsis related case fatality regardless of presenting 
stage of sepsis. Concerns of false deflations of sepsis-related mortality due to higher rates 
of reported diagnoses for sepsis appear not to play a major role in this study as we found 
both that rates of reported sepsis diagnoses were decreasing for our study and that percent 
from baseline changes were similar among sepsis, severe sepsis, and septic shock. Higher 
case fatality rates in older adults are possibly explained by differences in immune 
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function, presenting signs and symptoms of sepsis that may be more difficult to 
recognize, and weakened barrier functions.
34
 However, case fatality rates decreased 
among all age groups, suggesting that additional factors, such as improving evidence 
based treatments for sepsis, are having the intended effect.
17
 This combination of 
findings, with both decreases in POA diagnosis rates and case fatality rates, suggests that 
there is measurable improvement in the management and care of patients with sepsis. 
 This study has a number of limitations. First, by only including POA cases of 
sepsis, the findings of this study do not apply to cases of sepsis acquired within the 
hospital, although a small proportion of included hospitalizations may represent transfer 
of patients between care institutions who could represent healthcare acquired infections. 
Findings for POA cases of sepsis may represent potential opportunities for caregivers 
outside of inpatient settings to identify and begin management of patients with sepsis, 
thereby contributing to lower acuity at the time of hospital presentation and improved 
outcomes. Defining cases by ICD-9CM diagnoses means we may have missed instances 
of sepsis, particularly of severe sepsis. However, using this definition allows us to 
understand better what is being documented as a result of the POA implementation and 
offers a very specific rather than sensitive definition. We were unable to adjust for a 
number of other factors, such as severity of illness and comorbidities, that likely affect a 
patient’s course of illness and outcomes from sepsis. We were also unable to account for 
physican and other healthcare provider characteristics that may affect diagnosis and 
management, as volume of sepsis cases and clinical biases have been shown to play a role 
in identification and early recognition of patients with sepsis.
92,93
 Selection bias may 
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affect these results, as only hospitals who contributed data for all years of the study were 
included, and system level variables may affect decisions of which EHR system is used 
therefore affecting systematic documentation practices. Finally, the findings of this study 
may not be generalizable to hospital systems not using the Cerner EHR system.  
 This study adds to the existing body of evidence for epidemiologic trends of 
sepsis and extends the field by expanding to include hospitalizations through the 
midpoint of 2014. This study also leverages a large clinical database, and uses that to 
extend our study through the full spectrum of sepsis progression. While this study 
supports improvements in the treatment of patients with sepsis as evidenced by the 
decrease in case fatality rates, much work remains to be done to improve the recognition 
and care of patients with sepsis. With the recent move in the United States to ICD-10 
coding, as well as the implementation of new sepsis definitions, care guidelines, and 
reimbursement metrics,
9,11,13
 there remains a role for investigation into epidemiologic 
trends of diagnosis and mortality of sepsis and leveraging the power of large clinical 
datasets containing clinically relevant indicators. 
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Table 3.1: Baseline Characteristics by Fiscal Year 
 2008 
(n=9,777) 
2009 
(n=11,033) 
2010 
(n=8,146) 
2011 
(n=7,126) 
2012 
(n=4,767) 
2013 
(n=3,536) 
Age Group 
in Years  
      
18-34 5.8% 5.9% 6.1% 5.2% 6.7% 8.3% 
35-64 40.5% 42.8% 39.6% 38.7% 37.6% 40.1% 
65-74 19.4% 18.7% 19.5% 19.5% 22.0% 22.3% 
75-84 20.4% 20.0% 19.8% 19.7% 19.0% 16.9% 
85+ 14.0% 12.6% 16.0% 16.9% 14.7% 12.5% 
Presenting 
Stage of 
Sepsis 
      
Sepsis 61.0% 59.2% 58.9% 59.4% 60.1% 59.8% 
Severe 
Sepsis 
24.0% 25.6% 25.5% 25.6% 25.8% 26.8% 
Septic  
Shock 
17.1% 11.5% 15.6% 15.0% 14.1% 13.4% 
 
 
 
Table 3.2: Beta-estimates for Linear Regressions of Trends over Time 
 Diagnosis Rates Case Fatality Rates 
Presenting 
Stage 
Beta-estimate 
(95% Confidence interval) 
p-value for trend Beta-estimate 
(95% Confidence Interval) 
p-value for trend 
Sepsis 
 
-104.52 (-156.71 to -52.34) 0.0051 -1.77 (-2.49 - -1.05) 0.0014 
Severe Sepsis 
 
-40.13 (-67.03 to -13.23) 0.0143 -2.97 (-3.86 - -2.07) 0.0004 
Septic Shock 
 
-28.06 (-42.08 to -14.03) 0.0051 -3.25 (-4.28 - -2.23) 0.0004 
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Figure 3.1 Population Selection
 
8,146,180 Total Inpatient Hospitalizations 
10/01/2008 – 06/30/2014
5,090,729 Hospitalizations from 68 Hospitals Contributing Data 
to All Years of the Study 
45,581 Sepsis, Severe Sepsis, or Septic Shock Hospitalizations 
Present on Admission
4,953,314 Hospitalizations Excluded from Hospitals Not 
Contributing Data to All Years of the Study
5,045,148 Non-Sepsis Related Hospitalizations
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Figure  3.2: Sepsis Diagnoses per 100,000 Hospitalizations 
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Figure 3.3a: Sepsis Diagnoses by Age Group per 100,000 Hospitalizations  
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Figure 3.3b: Severe Sepsis Diagnoses by Age Group per 100,000 Hospitalizations  
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Figure 3.3c: Septic Shock Diagnoses by Age Group per 100,000 Hospitalizations  
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Figure 3.4: Case Fatality Rates for Patients with Sepsis, Severe Sepsis, or Septic Shock 
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Figure 3.5a: Case Fatality Rates for Patients with Sepsis by Age Group 
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Figure 3.5b: Case Fatality Rates for Patients with Severe Sepsis by Age Group 
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Figure 3.5c: Case Fatality Rates for Patients with Septic Shock by Age Group 
8
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Supplementary Table 3.1: ICD-9CM Diagnosis Codes for Sepsis, Severe Sepsis, and 
Septic Shock 
 ICD-9CM Codes 
Sepsis 995.91, 038  
Severe Sepsis  995.92 
Septic Shock 785.5 
 
 
 
Supplementary Table 3.2: Beta-Estimates from Linear Regression of Trends over Time for Age Subgroups 
 Diagnosis Rates Case Fatality Rates 
Presenting 
Stage 
Beta-estimate 
(95% Confidence interval) 
p-value for trend Beta-estimate 
(95% Confidence Interval) 
p-value for trend 
Sepsis 
18-34 
 
-23.70 (-54.05 to 6.64) 
 
0.0960 
 
-1.51 (-2.06 to -0.97) 
 
0.0008 
35-64 -108.73 (-178.38 to -39.08) 0.0123 -1.55 (-2.32 to -0.77) 0.0037 
65-74 -127.64 (-188.14 to -67.14) 0.0042 -1.43 (-2.40 to -0.46) 0.0128 
75-84 -143.95 (-199.64 to -88.26) 0.0020 -2.43 (-3.52 to -1.33) 0.0024 
85+ -146.63 (-180.57 to -112.68) 0.0003 -2.36 (-3.49 to -1.23) 0.0002 
Severe Sepsis 
18-34 
 
-7.03 (-14.03 to -0.03) 
 
0.0493 
 
-3.35 (-4.85 to -1.85) 
 
0.0023 
35-64 -42.33 (-75.48 to -9.18) 0.0239 -3.19 (-4.55 to -1.83) 0.0018 
65-74 -44.98 (-75.32 to -14.63) 0.0147 -2.25 (-2.95 to -1.54) 0.0004 
75-84 -55.50 (-89.37 to -21.63)  0.0104 -3.34 (-5.75 to -0.93) 0.0161 
85+ -64.87 (-94.19 to -35.56) 0.0036 -3.71 (-5.36 to -2.06) 0.0022 
8
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Septic Shock 
18-34 
 
-7.83 (-14.81 to -0.84) 
 
0.0359 
 
-3.81 (-6.21 to -1.42) 
 
0.0094 
35-64 -34.75 (54.28 to -15.19) 0.0079 -1.83 (-3.77 to -0.11) 0.0602 
65-74 -31.97 (-41.41 to -22.54) 0.0007 -4.63 (-5.65 to -3.60) <0.0001 
75-84 -33.45 (-55.54 to -11.36) 0.0136 -4.71 (-7.61 to -1.82) 0.0086 
85+ -26.65 (-37.01 to -16.28) 0.0020 -5.82 (-7.31 to -4.33) 0.0002 
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Supplementary Figure 3.1: All (POA and non-POA Inclusive) Sepsis Diagnoses per 100,000 Hospitalizations by Fiscal Year 
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Supplementary Figure 3.2: Number of Inpatient Encounters per Fiscal Year  
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CHAPTER IV 
PREDICTORS OF SUBSEQUENT SEPSIS READMISSION AFTER A SEPSIS 
HOSPITALIZATION 
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Abstract 
Objective: To identify predictors of subsequent readmissions for sepsis after an index 
hospitalization for sepsis 
Method: Using the Cerner HealthFacts
®
 Database, we identified 57,530 hospitalizations 
for sepsis, severe sepsis, and septic shock using a combination of ICD-9CM codes (038, 
785.52, 995.1, 995.92) and present-on-admission flags for adult inpatients after October 
1, 2008. Predictors of re-hospitalization (yes/no) were identified from a logistic 
regression model. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were 
reported  
Results: Of 50,089 patients who survived an index hospitalization with sepsis, 18.6% 
were readmitted within 30 days for all causes, and 1,380 were re-hospitalized for sepsis, 
severe sepsis, or septic shock within 30 days of their initial discharge. Increased risk of 
re-hospitalization for sepsis compared to patients not readmitted during the same time 
frame was found for patients who were initially admitted with sepsis due to abdominal 
infections (AOR: 1.22 95% CI: 1.05-1.43), patients discharged to hospice (AOR: 2.98 
95% CI: 2.41-3.68), patients initially admitted from a skilled nursing facility (AOR: 1.58 
95% CI: 1.28-1.95), and patients initially discharged to a skilled nursing facility 
(AOR:1.95 95% CI: 1.65-2.31). 22.3% of patients readmitted with sepsis expired during 
their subsequent hospitalization for sepsis.  
Conclusions: Patients readmitted within 30 days of a hospitalization for the same 
underlying cause, sepsis, reflect potential opportunities for improvements in patient care 
but also reflect the continued need for improved understanding of the long-term 
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implications of surviving sepsis.  Given increasing national pressure to reduce 
readmissions after sepsis healthcare encounters, understanding factors that may be 
amenable to modification is important. We found increased risk for sepsis readmissions 
among patients initially discharged to hospice, suggesting that there may be additional 
efforts needed to care for these complex patients in their preferred setting. 
  
 
 
 
89 
Introduction 
Hospital readmissions, especially those in the immediate time period following an 
initial hospitalization, have become a focus of national interest as they may represent 
initial quality of care as well as continuity of post-discharge care and potential 
opportunities for preventative efforts to reduce readmissions.
94
 The Centers for Medicare 
and Medicaid Services (CMS) have developed penalties for 30-day readmissions 
following an initial hospitalization for pneumonia, acute myocardial infarction, and 
stroke, all disease processes with clearly defined best practices for acute and post-acute 
care.
95–97
 CMS has indicated its movement towards targeting sepsis for a readmission 
reduction program with publication of the SEP-1 metrics
98
, but as of yet has not targeted 
reimbursement penalties to readmissions for sepsis.  
 Sepsis has traditionally been treated as an acute event, with patients surviving to 
discharge thought of as cured. However, current research is increasingly showing long 
term effects from sepsis ranging from decreased quality of life to immune effects 
resulting from the initial immunologic disarray.
37
 Case fatality rates have been steadily 
declining with corresponding reports of increases in diagnoses, resulting in an increased 
number of people who are at risk for subsequent readmission.
4
 Further, the aging of the 
US population has led to an increase in the number of people who are at higher risk for 
both an initial hospitalization for sepsis and at increased risk for all causes of 
readmission.
99
  
 Current research on readmissions of people initially surviving a sepsis 
hospitalization has consistently emphasized the high percentage of patients readmitted for 
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any cause and the high cost of these readmissions.
100
 These studies use a wide variety of 
techniques, time windows for readmissions, and definitions of sepsis resulting in 
readmission estimates ranging from 19-32%.
101
 A high percentage of these readmissions 
have been attributed to infectious causes in other studies
102,103
; however, little remains 
known about the frequency of repeat readmissions for sepsis among sepsis survivors. 
Increased attention to this population could illuminate potential areas for interventions to 
reduce readmission and to improve post-acute care, in addition to providing useful 
information about the ongoing immune effects of sepsis.  
 This study aims to identify predictors of 30-day readmissions for sepsis, severe 
sepsis, or septic shock among patients surviving an initial hospitalization for sepsis, 
severe sepsis, or septic shock.  
Methods 
Study Design and Setting 
 We conducted a retrospective cohort study using data extracted from the Cerner 
HealthFacts
®
 Database. The HealthFacts
®
 database is comprised of de-identified patient 
level information including information on their encounters and diagnoses. Over 500 
healthcare facilities use the Cerner system, representing 133 million inpatient and 
outpatient encounters from 84 million patients over two decades. Cerner corporation 
(Kansas City, MO) maintains the HealthFacts
®
 database.
48
 
Eligibility Criteria 
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 To be considered for the study, patients must have had a hospital stay during the 
study period, October 1,2008 through June 30 2014, be aged 18 years or older at 
admission, and have a diagnosis of sepsis, severe sepsis or septic shock at the time of the 
hospital admission. Diagnoses of sepsis, severe sepsis, and septic shock were determined 
using ICD-9CM codes (038, 785.52, 995.1, 995.92) from any coded field; however, the 
diagnosis must have been flagged as present-on-admission (POA) in the HealthFacts
®
 
Database. Finally, patients must have survived their initial hospitalization to be 
considered eligible for a subsequent readmission. 
 Index Hospitalizations 
Index hospitalizations were considered as the first hospitalization during the study 
period, and in concordance with the Agency for HealthCare Research and Quality 
definition of index hospitalizations, did not require a period free of hospitalizations prior 
to the index event.
104
  
Outcome: 30-Day Hospital Readmission 
 The primary outcome measure for this study was hospital readmission within 30 
days of the index discharge date due to sepsis, severe sepsis, or septic shock as identified 
by the previously listed ICD-9 CM codes and marked as POA. Patients who had multiple 
encounters represented within the database but that had a discharge date and subsequent 
admission date separated by less than 24 hours were considered to be part of the same 
hospitalization.  
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Potential Predictors of Hospital Readmission 
 Comorbidities, presenting stage of sepsis, age, sex, race, marital status, organ 
dysfunction during the index hospitalization, initial source of admission, discharge 
location from the index hospitalization, length of stay of index hospitalization, weekend 
admission, and source of index infection were considered potential predictors of 30-day 
readmission. Comorbidities were identified in accordance with those comorbidities 
considered in the Charlson-Deyo Comorbidity index.
63,105
 Presenting stage of sepsis was 
identified as the most highly acute form of sepsis at time of admission, e.g. if a patient 
had codes for both septic shock and severe sepsis noted as POA, the patient would be 
classified as having presented with septic shock. Age was divided into categories from 
18-35, 35-64, 65-74, 75-84, and 85+ with the latter three categories corresponding to the 
census categories for the young old, old old, and oldest old.
106
 Sex has been explored in 
the literature as a predictor of both sepsis outcomes and hospital readmissions.
65
 
Although race data are notoriously misclassified in hospital and claims data, nevertheless 
racial disparities in sepsis outcomes and readmissions have been documented and warrant 
further investigation.
107,108
 Marital status has been shown to be an important proxy for 
social support and to impact likelihood of readmissions.
109
 Organ dysfunction during the 
initial hospitalization indicates more severe illness.
110
 Patients admitted from skilled 
nursing facilities (SNF) are likely to have different pathogen mixes and be more prone to 
repeat admission, and patients who are discharged to a SNF after a hospitalization are 
more likely to experience a readmission.
103
 Length of stay during the initial 
hospitalization has been established as a predictor of both sepsis hospitalizations and 
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readmissions.
103
 Admission through the emergency department has been associated with 
improved hospital outcomes for patients with sepsis
66,111
, and admission on weekends 
compared to weekdays has been associated with poorer outcomes.
112
 Initial source of 
infection is associated with differences in sepsis hospitalization outcomes, and certain 
infections may be prone to repeat hospitalization.
33
 Patients with infections identified at 
the start of their hospital admission  using ICD-9CM codes (Supplementary Table 4.1) 
and the POA flag were classified into one of the following infection groups: respiratory, 
gastrointestinal (GI), genitourinary (GU), skin, soft tissue, and bone (SSTB), and central 
nervous system (CNS).   
Statistical Analyses 
 We summarized patient characteristics by readmission status. Proportions were 
reported for categorical variables, and data were summarized by means and standard 
deviations, or medians and interquartile ranges for normally and non-normally distributed 
continuous variables respectively. Unadjusted logistic regression models were used to 
examine the association between each potential predictor of readmission and 30-day 
readmission for sepsis, severe sepsis, or septic shock. A complete, adjusted logistic 
regression was then fit to the data to examine all potential predictors of 30-day 
readmission for sepsis, severe sepsis, or septic shock. Crude and adjusted odds ratios 
(ORs, AORs), 95% confidence intervals (95% CI), and two-sided p-values are reported. 
SAS 9.4 was used for all analyses. 
Ethical Considerations 
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This research was deemed not human subjects research by the University of 
Massachusetts Institutional Review Board; the informed consent requirement was 
waived.  
Results 
During the study period, there were 8,146,180 adult inpatient encounters. Of these 
encounters, 57,530 patients were admitted with a diagnosis of sepsis, severe sepsis, or 
septic shock. Almost 13% of these patients expired before hospital discharge, leaving 
50,089 sepsis survivors. Of these survivors, 40,770 were not readmitted to the same 
healthcare system within 30 days, while 9,319 patients were readmitted within 30 days 
for any cause. Of these readmitted patients, 1,380 were admitted with a diagnosis of 
sepsis, severe sepsis, or septic shock. (Figure 4.1)  
 A majority of the patients included in this study were over the age of 65 among 
both the group of survivors who were readmitted within 30 days of their initial discharge 
and those who were not. Approximately three-quarters of the patients included were 
identified as white, and one-third of patients were married. One quarter of patients were 
admitted on a Saturday or Sunday. Patients who were readmitted with sepsis within 30 
days of their initial discharge had a median length of index hospital stay of 8 days 
(interquartile range 4-13 days) while patients who survived an index hospitalization of 
sepsis and were not re-hospitalized within 30 days had a median length of stay of 7 days 
during their index admission (interquartile range 4-11 days). (Table 4.1)  
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 Among the patients readmitted within 30 days with sepsis, severe sepsis, or septic 
shock, the median length of stay was 6 days (interquartile range 3-11 days). The majority 
of patients (59.1%) who were readmitted within 30 days initially presented with sepsis 
rather than severe sepsis or septic shock. Nearly one quarter (22.3%) of patients 
readmitted within 30 days died during this subsequent hospitalization, and one quarter 
were discharged to a SNF while 7.8% were discharged to hospice. (Table 4.2) 
 The mix of infections present at the time of initial admission was relatively even 
between groups, with approximately 30% of patients having a respiratory infection, 40% 
of patients having a GU infection, 12-13% having SSTB infections, and less than 1% 
having CNS infections. Among patients who were readmitted within 30 days just over 
15% had a GI infection during the index admission while 11.8% of those patients not 
readmitted within 30 days had a GI infection. Among those who had an initial 
hospitalization with a respiratory infection, 51.9% also had a respiratory infection at the 
time of readmission, while 12.5% had a GI infection, 31.9% had a GU infection, 9.1% 
had a SSTB infection and 0.3% had a CNS infection. Some patients had multiple 
infections at the time of readmission, therefore percentages do not sum to 100 percent. 
Among patients who were readmitted within 30 days with sepsis who initially had a GI 
infection, 46.6% were readmitted with a GI infection while 24.6% were readmitted with a 
respiratory infection, 29.6% were readmitted with a GU infection, 11.4% were readmitted 
with a SSTB infection and 0.8% were readmitted with a CNS infection. For patients who 
had an index admission with a GU infection, 64.7% were also readmitted with a GU 
infection. 25.6% of patients initially admitted with a GI infection were later readmitted 
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with a respiratory infection, while 14.0% were readmitted with a GI infection, 9.6% were 
readmitted with a SSTB infection and 0.3% were readmitted with a CNS infection. Of the 
patients who were initially admitted with a SSTB infection, 44.1% had a SSTB infection 
at the time of readmission while 18.5% had a respiratory infection, 12.7% had a GI 
infection, 31.0% had a GU infection and 0.7% had a CNS infection. (Figure 4.2) Of note, 
on closer examination of the breakdown of GI infections, 8.6% of patients readmitted 
within 30 days with sepsis, severe sepsis, or septic shock had an initial diagnosis of 
Clostridium diffiicle with 11.2% of patients having a diagnosis of Clostridium difficile on 
readmission at 30 days.  
Unadjusted analyses revealed associations between increased age, number of 
comorbidities, index hospitalization length of stay of greater than or equal to 7 days, 
initial abdominal infection, discharge to SNF or discharge to hospice, and admission from 
a SNF and increased risk of readmission to the same hospital system within 30 days with 
sepsis, severe sepsis, or septic shock. Additionally, unadjusted analyses revealed 
associations between admission with severe sepsis or septic shock rather than sepsis, or 
organ failure on the index hospitalization excluding cardiovascular failure and 
readmission to the same hospital system with sepsis, severe sepsis, or septic shock within 
30 days. (Table 4.3) 
Adjusted models revealed associations between 1-3 Charlson-Deyo comorbidities, 
4+ Charlson-Deyo comorbidities, initial abdominal source of infection, discharge to a 
SNF or hospice, hematologic failure during the index hospitalization, and admission from 
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a SNF with an increased risk of re-hospitalization with sepsis, severe sepsis, or septic 
shock within 30 days. These associations persisted with adjustment for other 
demographic characteristics and hospitalization characteristics. (Table 4.3)  
Discussion 
This study investigates potential predictors of readmission with sepsis, severe 
sepsis, or septic shock within 30 days of discharge from a hospitalization for sepsis, 
severe sepsis, or septic shock. Among patients who survived to discharge from an initial 
hospitalization, 2.8% of patients were readmitted within 30 days with a sepsis diagnosis. 
This study found that initial discharge to hospice or to a SNF, initial admission from a 
SNF, initial abdominal infection, and a Charlson-Deyo comorbidity index score greater 
than 1 were associated with an increased risk of readmission with a sepsis spectrum 
diagnosis within 30 days after an initial survived hospitalization for a sepsis spectrum 
diagnosis. In addition, we investigated the mix of infections present on re-admission to 
the hospital, and found that in many cases at the re-hospitalization, infections were 
present in the same organ system as at the start of the initial hospitalization.  
Recent attention to the readmission of patients with sepsis for any cause has 
illustrated the high prevalence and cost of these readmissions.
59,113,114
 Our study’s all-
cause readmission risk of 22% is consistent with other studies of readmissions of patients 
initially hospitalized for sepsis. Additionally, other studies have found high rates of 
readmissions due to infections, accounting for nearly half of readmissions after sepsis 
depending on the time period evaluated
100,103
, but have not directly investigated the 
 
 
 
98 
nature of patients who have been re-hospitalized with sepsis and the predictors of these 
readmissions. Our study expands the current literature by investigating predictors of 
readmissions for those patients who are readmitted with the same condition as their initial 
hospitalization.  
Our study observed that patients who were initially discharged to hospice were 
almost three times as likely to be readmitted with a sepsis diagnosis within 30 days 
compared to patients who were discharged home. On the surface, this finding may appear 
to be counterintuitive as the goals of hospice care are generally palliative and patients and 
their families often expressly voice a desire to avoid additional hospital stays.
115,116
 
However, the phenomenon of re-hospitalization after transfer to hospice care has been 
documented as part of a concern that hospice benefits may seek to avoid paying for costly 
hospitalizations; those patients who elected to receive hospice care due to an infectious 
diagnosis were more than twice as likely than patients who elected hospice care due to a 
diagnosis of cancer to be rehospitalized.
117
 Our study adds weight to the concern that the 
rapid expansion of hospice benefits has created a need for additional support of 
caregivers, both paid and familial, to further understand how best to manage the comfort 
of their patient or loved one. Additional support in the form of more detailed instructions 
on how to manage common symptoms of escalating infection that cause patient 
discomfort such as shortness of breath, rapid heart rate, and altered mental status, could 
lead to an improvement of care for patients in concordance with their wishes and peace of 
mind for caregivers who may elect hospitalization out of the concern and fear of 
watching distressing symptomatic manifestations of acute illness. Additionally, patients 
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and their families may have found relief and reassurance in therapies administered at the 
hospital and determining what those therapies were and if they can be administered in a 
hospice setting may alleviate readmission burden among these patients.  
 This study found an association between admission to the hospital from a SNF 
and readmission to the hospital within 30 days with a repeat diagnosis of sepsis compared 
to patients who were admitted from other settings. We also observed an association 
between patients who were discharged to a SNF and readmission to the hospital within 30 
days with a subsequent diagnosis of sepsis. The “revolving door” pattern of SNF stays 
and rehospitalizations has been well documented previously.
118
 Many possibilities exist 
for these associations, including that patients who are cared for in SNFs generally have 
poorer health and greater numbers of comorbidities. However, there may still be 
additional opportunities to improve care for patients in SNFs to alleviate the burden of 
readmissions and break the cycle of frequent hospitalizations through improved post-
discharge care.  
 The primary focus of this study was the risk of readmission with sepsis after an 
index hospitalization for sepsis. Although the inciting infection for sepsis may not always 
be known despite efforts to collect blood cultures prior to antibiotic administration, 
nevertheless the initial source of infection for many patients may provide valuable insight 
into the disease process and possible sequelae the patient may experience as a result. In 
our study, patients who initially presented to the hospital with sepsis likely due to a GI 
infection were more likely to be readmitted with a subsequent diagnosis of sepsis, and 
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nearly half of these readmissions were also for a GI source of infection. Some GI 
infections, such as C.difficile, are known to have high rates of recurrence
119
 and our study 
did find that 70% of patients readmitted for sepsis with a GI infection had a diagnosis of 
C. difficile. Among patients who were readmitted after an initial hospitalization for sepsis 
and a GU infection, nearly two-thirds of these patients also had a diagnosis of a GU 
infection during the readmission. These findings suggest that some patients with certain 
infection types may be at particularly high risk for repeated infections. Efforts to identify 
these patients could prevent the progression of infection to sepsis if appropriate 
interventions, such as removal of indwelling catheters, may be implemented and found to 
be beneficial to preventing additional hospitalizations. 
This study has a number of limitations. First, the use of ICD-9 CM codes to 
explicitly define patients with sepsis, severe sepsis, or septic shock results in a specific 
rather than a sensitive definition of sepsis. This definition provides the advantage that 
very few false positive cases are likely to have been included in this study; however, 
there may be limited inferences able to be made to patients with sepsis defined according 
to other strategies. Nearly all studies of readmissions suffer from an inability to identify 
patients who were readmitted to hospital systems outside of the location of the initial 
index hospitalization and this study is no exception. Similarly, we were unable to account 
for patients who died outside of the hospital and future investigations would benefit from 
strategies accounting for competing risks. An important future direction of research is to 
include long-term follow-up of patients discharged after a hospitalization for sepsis to 
better understand the trajectory of these patients, and how it relates to their health 
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trajectory prior to their hospitalization. There may be misclassification of the predictors 
considered in this study and there are elements of care such as time to administration of 
appropriate antibiotics and other unmeasured characteristics of patients with sepsis that 
we were unable to account for. Nonetheless, we believe that this study offers valuable 
insights into the nature of patients who are repeatedly hospitalized for sepsis and provides 
potential new directions for future investigations. 
 This study leveraged a national EHR database to investigate readmissions for 
patients who had an additional episode of sepsis within 30 days of discharge for an initial 
hospitalization with sepsis. Given that sepsis exacts a high cost in terms of mortality, 
morbidity, and quality of life for patients and high financial costs for healthcare systems, 
understanding correlates of additional episodes of sepsis may generate further insights to 
strengthen care of individual patients and improvements to the healthcare delivery system 
to tackle this heterogeneous, multi-faceted problem.  
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Table 4.1: Demographic and Clinical Characteristics of Patients’ Index Hospitalization 
for Sepsis by Readmission Status 
 
 
  
 Sepsis Survivors 
without a 30-day 
Readmission 
(n=40,770) 
Sepsis Survivors 
Readmitted within 
30 days 
(n=1,380) 
Demographic Characteristics 
  Percentage  
Age (years) 18-34 7.3 3.6 
 35-64 39.7 38.6 
 65-74 20.0 22.6 
 75-84 19.5 19.8 
 85+ 13.5 15.4 
Women  51.4 48.5 
Race    
 White 74.9 74.3 
 Black  18.2 20.3 
 Other or Unknown 6.9 5.4 
Married 36.8 37.0 
Charlson-Deyo Comorbidity Index   
0 18.6 10.1 
1-3 53.3 53.0 
4+ 28.1 36.8 
Hospitalization Characteristics 
Weekend Admission 25.7 24.1 
Length of Stay in Days (Median, 
IQR) 
7.0 (4.0-11.0) 8.0 (4.0-13.0) 
Initial Infection Source   
Respiratory  27.5 29.2 
Abdominal 11.8 15.3 
Genitourinary 39.2 39.1 
Skin, Soft Tissue, and Bone Infection 13.7 12.4 
Central Nervous System 0.8 0.7 
Organ Failures   
Cardiovascular 12.8 13.2 
Hematologic 13.4 17.8 
Hepatic 1.8 2.6 
Neurologic 10.8 14.4 
Renal 35.9 41.8 
Respiratory 24.1 27.2  
Admission Source   
Emergency Department 31.2 28.8 
Transfer from a Skilled Nursing 5.1 9.6 
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Facility (SNF) 
Physician or Clinic Referral 47.2 42.8 
Other 16.5 18.8 
Discharge Location   
Home 38.4 23.1 
SNF 23.2 31.4 
Hospice 5.1 11.2 
Other 33.3 34.3 
Presenting Stage of Sepsis   
Sepsis 65.5 58.6 
Severe Sepsis 16.4 18.2 
Septic Shock 18.1 23.3 
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Table 4.2: Characteristics of the Subsequent Hospitalization for Patients Re-hospitalizaed 
with Sepsis  
 
 
  Characteristic 
 Sepsis Survivors 
Readmitted within 
30 days 
(n=1,380) 
Length of Stay in Days (Median, 
IQR) 
6.0  (3.0-11.0) 
 Percentage  
Admission Source  
Emergency Department 19.1 
Transfer from a SNF 11.3 
Physician or Clinic Referral 40.7 
Other 28.8 
Discharge Location  
Home 19.0 
SNF 23.6 
Hospice 7.8 
Other 27.3 
Deaths 22.3 
Presenting Stage of Sepsis  
Sepsis 59.1 
Severe Sepsis 18.6 
Septic Shock 22.3 
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Table 4.3: Effect Estimates for Predictors of 30-day Re-hospitalization with Sepsis   
 
 
   
 Odds Ratio 
(95% CI) 
Adjusted Odds Ratio 
(95% CI) 
Demographic Characteristics 
Age (years) 18-34 Ref Ref 
 35-64 1.96 (1.47-2.63, 
p<0.0001) 
1.44 (1.07-1.95, 
p=0.0161) 
 65-74 2.28 (1.69-3.09, 
p<0.001) 
1.44 (1.06-1.97, 
p=0.0216) 
 75-84 2.05 (1.51-2.78, 
p<0.0001) 
1.20 (0.87-1.65, 
p=0.2667) 
 85+ 2.31 (1.70-3.16, 
p<0.0001) 
1.28 (0.92-1.78, 
p=01441) 
Women  0.89 (0.80-0.99, 
p=0.0319) 
0.91 (0.82-1.02, 
p=0.0965)  
Race    
 White Ref Ref 
 Black  1.12 (0.98-1.29, 
p=0.0917) 
1.09 (0.95-1.26, 
p=0.2225) 
 Other or 
Unknown 
0.80 (0.63-1.01, 
p=0.0622) 
0.85 (0.67-1.07, 
p=0.1673) 
Married 1.01 (0.90-1.13, 
p=0.8645) 
1.06 (0.94-1.19, 
p=0.3710) 
Charlson-Deyo Comorbidity Index   
0 Ref Ref 
1-3 1.82(1.52-2.19, 
p<0.0001) 
1.57 (1.30-1.89, 
p<0.0001) 
4+ 2.40 (1.98-2.89, 
p<0.0001) 
1.83 (1.50-2.22, 
p<0.0001) 
Hospitalization Characteristics 
Weekend Admission 0.92 (0.81-1.04, 
p=0.1912) 
0.92 (0.81-1.04, 
p=0.1906) 
Length of Stay  7 Days  1.33 (1.20-1.49, 
p<0.0001) 
1.03 (0.91-1.16, 
p=0.6305) 
Initial Infection Source   
Respiratory  1.09 (0.97-1.22, 
p=0.1697) 
1.07 (0.94-1.21, 
p=0.2984) 
Abdominal 1.35 (1.16-1.57, 
p<0.0001) 
1.22 (1.05-1.43, 
p=0.0117) 
Genitourinary 0.99 (0.89-1.11, 
p=0.9195) 
0.98 (0.87-1.10, 
p=0.6935) 
Skin, Soft Tissue, and Bone Infection 0.90 (0.76-1.05, 
p=0.1810) 
0.89 (0.75-1.05, 
p=0.1652) 
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Central Nervous System 0.94 (0.50-1.77, 
p=0.8456) 
0.94 (0.50-1.77, 
p=0.8448) 
Discharge Location   
Home Ref Ref 
SNF 2.25 (1.94-2.61, 
p<0.0001) 
1.95 (1.65-2.31, 
p<0.0001) 
Hospice 3.64 (2.99-4.43, 
p<0.0001) 
2.98 (2.41-3.68, 
p<0.0001) 
Other 1.71 (1.48-1.98, 
p<0.0001) 
1.56 (1.34-1.81, 
p<0.0001) 
Presenting Stage of Sepsis   
Sepsis Ref Ref 
Severe Sepsis 1.24 (1.08-1.44, 
p=0.0032) 
1.07 (0.91-1.25, 
p=0.4124) 
Septic Shock 1.44 (1.26-1.64, 
p<0.0001) 
1.17 (1.01-1.36, 
p=0.0357) 
Organ Failures-Index 
Hospitalization 
  
Cardiovascular 1.04 (0.89-1.22, 
p=0.6401) 
0.92 (0.79-1.08, 
p=0.3236) 
Hematologic 1.40 (1.22-1.61, 
p<0.0001) 
1.24 (1.07-1.43, 
p=0.0040) 
Hepatic 1.45 (1.03-2.03, 
p=0.0320) 
1.04 (0.73-1.48, 
p=0.8198) 
Neurologic 1.38 (1.18-1.61, 
p<0.0001) 
1.09 (0.93-1.28, 
p=0.2960) 
Renal 1.28 (1.15-1.43, 
p<0.0001) 
1.03 (0.92-1.17, 
p=0.5964) 
Respiratory 1.18 (1.04-1.33, 
p=0.0088) 
0.90 (0.79-1.04, 
p=0.1402) 
Index Admission Source   
Emergency Department Ref ref 
Transfer from a Skilled Nursing 
Facility (SNF) 
2.04 (1.67-2.50, 
p<0.0001) 
1.58 (1.28-1.95, 
p<0.001) 
Physician or Clinic Referral 0.99 (0.87-1.12, 
p=0.8184) 
1.01 (0.88-1.15, 
p=0.9331) 
Other 1.24 (1.06-1.45, 
p=0.0089) 
1.10 (0.94-1.31, 
p=0.2096) 
 
 
  
Figure 4.1: Population Selection
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Figure 4.2: Initial Infection Source and Subsequent Infection Source at 30-day Re-hospitalization for Sepsis, Severe Sepsis, or 
Septic Shock
 
*Huma n illustration by Mikael Häggström (All used images are in public domain) [CC0], via Wikimedia Commons, Numbers 
presented superimposed on image are from this study 
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Supplementary Table 4.1: ICD9-CM Codes for Sepsis Identification, Infection Source 
and Organ Dysfunction Classification 
 ICD-9CM Codes 
Sepsis 995.91, 038  
Severe Sepsis  995.92 
Septic Shock 785.5 
Respiratory Infections 010, 011, 012, 013, 014, 015, 016, 017, 018, 032, 033, 
034, 461, 462, 463, 464, 465, 480, 481, 482, 483, 484, 
485, 486, 491.21 
Abdominal Infections 001, 002, 003, 004, 005, 008, 0845, 009, 540, 541, 542, 
543.9, 562.01, 563.203, 562.11, 562.13, 566, 567, 569.5, 
569.61, 569.71, 569.83, 572, 575 
Genitourinary Infections 590, 595, 597, 598, 599, 601, 604, 614, 615, 616 
Skin, Soft Tissue, and Bone 
Infections 
451, 680, 681, 682, 683, 686, 711, 728.86, 730, 785.4 
Central Nervous System Infections 036, 090, 320, 322, 324, 325 
Cardiovascular Failure 375, 376.6, 458, 785.5 
Hematologic Failure 286.6, 286.9, 287.4, 287.5 
Hepatic Failure 570, 573.4 
Neurologic Failure 293, 348.1, 348.3 
Renal Failure 584 
Respiratory Failure 335, 518.8, 786.03, 799.1, 967  
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CHAPTER V 
 DISCUSSION AND CONCLUSIONS 
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 Overall Purpose 
The overall purpose of this dissertation was to better understand: 1) the 
underlying epidemiology of POA sepsis and the role of the initial infection source as 
related to in-hospital mortality from sepsis; 2) recent trends in POA sepsis diagnosis and 
case fatality rates, in the context of the overall trends of increasing sepsis diagnoses and 
falling sepsis mortality; and 3) predictors of 30-day subsequent readmission with sepsis 
for patients who were initially hospitalized with sepsis.  
 Role of Infection Source across Chapters II and IV  
Prior research has investigated the role of initial infection source as it relates to 
hospital mortality with inconclusive or contradictory findings.
33,52,53
 Prior studies 
examining in-hospital mortality and initial infection source used many different means of 
identifying infections and creating exposure categories, and this heterogeneity has 
contributed to different conclusions being reached.
33,52,53,120
 This dissertation evaluated 
the role of the initial infection source and its relationship with both in-hospital mortality 
and 30-day readmissions due to sepsis. Through careful curation of ICD9-CM codes 
related to infections, categories that were determined to be of broad clinical relevance 
were created. For both Chapters II and IV, microbiology data was not included in the 
assessment of these categories. We did not pursue the inclusion of microbiological data 
as this information is often not readily available at the time of the patient’s presentation 
and we hoped for these studies to provide epidemiologic information that might be of use 
to the initial evaluating clinician. 
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In Chapter II, we presented findings that indicate patients presenting with initial 
GU or SSTB infections experienced lower rates of time to in-hospital mortality when 
compared to patients presenting with respiratory infections. In Chapter IV, we evaluated 
predictors of 30-day readmissions with sepsis, and did not find that initial GU or SSTB 
infections were associated with either an increased or decreased risk of re-hospitalization 
with a subsequent sepsis diagnosis. Given that patients with GU or SSTB infections are 
more likely to survive their initial hospital stay, it might be expected that more of these 
patients would be represented among those patients with sepsis re-hospitalizations within 
30 days. The observation that these patients are not overrepresented among patients who 
are readmitted with sepsis suggests a number of potential explanations. Patients with 
initial GU or SSTB infections may have had their underlying infections definitively 
cured, and had factors that predisposed them to the initial infection sufficiently modified, 
through means such as operative source control and removal of blockages, that they did 
not experience recurrence. Alternatively, it is possible that these patients after 
experiencing an infection that progressed to sepsis, were able to identify infections prior 
to progression to sepsis and sought treatment earlier. It is also possible, though somewhat 
unlikely that patients with GU or SSTB infections were more likely to die outside of a 
hospital setting, therefore precluding their inclusion by a readmissions study, but would 
also prevent their death from being captured by a study of hospital mortality. The work 
presented in this dissertation indicates a pressing need to further understand the long term 
outcomes of patients affected by sepsis. 
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While other studies have reported increased rates of hospital mortality for patients 
presenting with sepsis due to a GI infection
79,121
, our findings from Chapter II do not 
support that conclusion; however, we did find that patients with an initial sepsis 
hospitalization due to a GI infection source were more likely to experience 
rehospitalization for sepsis within 30 days than those patients presenting with other types 
of infections. We have postulated a number of potential explanations for this finding, 
including that certain GI infections such as those caused by C. difficile are more likely to 
recur than other types of infections. It is also possible that patients with GI infections may 
delay to seek care due to misattribution of symptoms and therefore their infections may 
progress to sepsis before care is sought. Care for intra-abdominal infections may also 
have substantially improved in the years following the initial studies examining the 
associations between infection source and hospital mortality. Indeed, care protocols have 
been changing for disease processes that were once thought to be settled, such as the 
growing movement towards interval appendectomy for patients with complicated, 
perforated appendicitis, but it is unclear what effect changes of individual infection 
management has had thus far on outcomes for patients with sepsis.  
Role of Age among Patients with Sepsis across Chapters II, III, and IV 
Chapters II-IV each examined the role of age among patients with sepsis, albeit in 
different manners. Prior clinical and basic science work has provided evidence for 
differences of immune function among older adults
56
, and older adults often have broader 
representation of comorbidities associated with aging including cardiovascular and 
pulmonary diseases, in addition to general structural changes such as the weakening of 
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barrier structures like the complex network of proteins of the skin.
122
 Older patients have 
less physiologic reserve than younger patients and may also have different goals of care 
for critical illness than younger, previously healthy patients.
123
 Sepsis is known to 
disproportionately affect older adults
54
, as reflected in Chapter III of this dissertation; 
however the improvement in case fatality rates seen regardless of age suggests that 
campaigns emphasizing sepsis recognition have had beneficial effects across broad 
groups of patients. Age was also a consideration when evaluating predictors for 30 day 
readmissions due to sepsis, and there is some evidence that a survivor effect may take 
place, i.e. those patients who survive to the oldest ages have generally better health status 
than their peers who may have met death earlier.
124–127
 Further, as shown in Chapter II of 
this dissertation, relative mortality of initial infection source did not markedly change 
within age strata. Taken together, these findings suggest that the fundamental dysfunction 
of sepsis may not markedly vary with age, but that there may be many factors that play a 
role at the complex intersection of aging and sepsis pathophysiology. 
 Role of Presenting Stage of Sepsis across Chapters II, III and IV 
We considered the role of presenting stage of sepsis across Chapters II-IV of this 
dissertation. There is an undeniable need for early intervention for patients with sepsis to 
prevent catastrophic outcomes, with documented increases of mortality of 8% for every 
hour that care is delayed.
22,128
 While there may always be patients whose underlying 
infection progresses so rapidly as to lead to these patients presenting when they are 
already critically ill, early identification of patients at risk of sepsis must remain a priority 
as to maximize the possibility of positive results, whether through definitive curative care 
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or through earlier initiation of conversations surrounding the patient’s goals of care, 
particularly for those near the end of life, where death is not necessarily a negative 
outcome.
129,130
 Patients presenting for care who have already progressed to severe sepsis 
or septic shock have unequivocally higher rates of mortality. Current changes circulated 
for definitions of sepsis essentially eliminate the category of sepsis as a stage, due to the 
difficulties of potentially overidentifying patients with sepsis due to the lack of specificity 
present in the SIRS criteria.
9
 However, adoption of this definition, while potentially 
useful in some contexts for identifying “true” cases of sepsis may also have repercussions 
for patient care which will be difficult to ameliorate. 
Implications of Considering Present-on-Admission Diagnoses of Sepsis Only 
Limiting our analyses to POA cases of sepsis intimates that these cases of sepsis 
are primarily community-acquired, which has a number of potential implications. 
Community- acquired sepsis presents opportunities for primary prevention taking the 
form of identifying, treating, and managing patients who develop infection prior to 
progression to sepsis. Educating all patients, but particularly those patients with comorbid 
conditions such as diabetes and immunosuppressive conditions that predispose them to 
infections with strategies to prevent infection may relieve some of the burden of sepsis 
among these patients. Understanding the epidemiology of POA cases of sepsis is also 
relevant as patient education efforts to increase awareness of sepsis are undertaken. These 
campaigns, such as the one by the Centers for Disease Control and Prevention 
encouraging patients to ask “Do you think this might be sepsis?”, cannot be understood 
without the context of the underlying epidemiology. Evaluating POA cases of sepsis also 
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has relevance to hospital systems and payers as CMS considers reimbursement penalties 
to hospitals for sepsis quality metrics such as SEP-1.
131
 With the changing environment 
of healthcare and reimbursement, the issues surrounding sepsis reimbursement require a 
thorough understanding of where outcomes may be most impacted. This includes 
understanding how sources of sepsis impact mortality differentially, and raising the 
possibility that other factors should be considered with potential reimbursement metrics, 
particularly since definitive treatment for sepsis has not yet moved past the guidelines of 
antibiotics, fluid resuscitation, and support for organ dysfunction despite sensational 
news reporting of potential “cures”.19,132  
Overall Limitations of this Dissertation 
While this dissertation addresses several questions about the underlying 
epidemiology of sepsis, there are a number of questions raised by this work and 
limitations of its design and scope. First, this dissertation relies on ICD-9CM coded 
definitions of sepsis, severe sepsis, and septic shock. This definition ensures that the 
cases detected are specific for sepsis, but means that a number of cases of sepsis were 
likely excluded from this analysis.
133
 These cases may have had sepsis, but not been 
identified in the clinical documentation as such. Further research should be conducted 
using alternate definitions of sepsis to examine whether associations are consistent. This 
dissertation work focused on POA cases of sepsis, therefore the conclusions may not be 
generalizable to those cases of sepsis acquired in the hospital. Administrative data has a 
number of inherent limitations,
134
 and conclusions drawn from these data sources cannot 
replace data collected through experimental designs. However, given ethical implications 
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and temporal limitations, administrative data provides valuable insight into patterns of 
healthcare use and associations generating hypotheses that can be tested in future work.  
Clinical Implications of this Dissertation 
Sepsis is a disease process which has been known about for centuries, and yet 
there remains many questions about sepsis epidemiology, treatment, identification, and 
follow-up care.
135
 Further work is needed to understand this heterogeneous, complex 
disease process, and how best to care for patients with sepsis who encounter an often-
fragmented healthcare system. Care providers need additional support and evidence to aid 
in identifying these patients, initiating the best possible care for a given individual, and 
planning for the long-term effects of sepsis and the need for patient supports. Healthcare 
systems need to enable communication interdisciplinarily and interprofessionally to 
create comprehensive plans for caring for all patients, therefore improving care for 
patients with sepsis. These findings add granularity to research on sepsis, and provide 
support for future innovations of care for patients with sepsis including more tailored 
approaches to treatment. 
Future Research Implications of this Dissertation 
This dissertation generates new hypotheses even as it potentially contributes to 
the understanding of the underlying epidemiology of sepsis. Questions raised by Chapter 
II include whether initial infection source, independent of microbiology, maintains an 
association with in-hospital mortality when further subdivisions are applied to exposure 
categories e.g. what is the differential impact of uncomplicated cystitis vs pyelonephritis 
if both infections progress to sepsis? When controlling for underlying dysfunction in an 
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organ, pathogen species, and other factors, do differences in the infection source play an 
independent role in mortality from sepsis? Chapter III raises the question of whether 
documentation and reporting changes advocated by CMS have sufficiently stabilized to 
use these trends as estimates for future clinical planning. Chapter III also raises the 
question of precisely which elements of improved sepsis care are driving the decline in 
mortality from sepsis. Chapter IV raises questions including what can be done to support 
patients after they are discharged from the hospital, as well as which infections may need 
more intense follow-up care for survivors of sepsis. Understanding how best to provide 
non-curative care to patients in a way that is sensitive to their needs for those who have 
elected hospice is a pressing concern with the increase in hospice providers and services 
available. Future qualititative work may be necessary to understand the wishes and needs 
of patients and their caregivers who are discharged to hospice with an infectious 
diagnosis. Across all chapters, there remains a need to better understand long-term 
outcomes of patients with sepsis and to improve long-term models of care.  
Final Summary 
Overall, our studies describe a number of characteristics of patients with POA 
sepsis. The findings that patients with GU or SSTB infections had lower rates of in-
hospital mortality than patients with respiratory infections contributes to the literature in 
this domain. Further, we extended the knowledge of recent trends in sepsis diagnoses and 
mortality and how these trends are observed for POA cases of sepsis. Finally, we 
identified a particularly vulnerable group of patients and identified predictors of re-
hospitalization that warrant future study.  
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